Interferons	O
inhibit	O
activation	O
of	O
STAT6	B-protein
by	O
interleukin	B-protein
4	I-protein
in	O
human	B-cell_type
monocytes	I-cell_type
by	O
inducing	O
SOCS-1	B-DNA
gene	I-DNA
expression	O
.	O

Interferons	B-protein
(	O
IFNs	B-protein
)	O
inhibit	O
induction	O
by	O
IL-4	B-protein
of	O
multiple	O
genes	O
in	O
human	B-cell_type
monocytes	I-cell_type
.	O

However	O
,	O
the	O
mechanism	O
by	O
which	O
IFNs	B-protein
mediate	O
this	O
inhibition	O
has	O
not	O
been	O
defined	O
.	O

IL-4	B-protein
activates	O
gene	O
expression	O
by	O
inducing	O
tyrosine	O
phosphorylation	O
,	O
homodimerization	O
,	O
and	O
nuclear	O
translocation	O
of	O
the	O
latent	B-protein
transcription	I-protein
factor	I-protein
,	O
STAT6	B-protein
(	O
signal	B-protein
transducer	I-protein
and	I-protein
activator	I-protein
of	I-protein
transcription-6	I-protein
)	O
.	O

STAT6	B-protein
-responsive	O
elements	O
are	O
characteristically	O
present	O
in	O
the	O
promoters	B-DNA
of	O
IL-4-inducible	B-DNA
genes	I-DNA
.	O

Because	O
STAT6	B-protein
activation	O
is	O
essential	O
for	O
IL-4	B-protein
-induced	O
gene	O
expression	O
,	O
we	O
examined	O
the	O
ability	O
of	O
type	O
I	O
and	O
type	O
II	O
IFNs	B-protein
to	O
regulate	O
activation	O
of	O
STAT6	B-protein
by	O
IL-4	B-protein
in	O
primary	B-cell_type
human	I-cell_type
monocytes	I-cell_type
.	O

Pretreatment	O
of	O
monocytes	B-cell_type
with	O
IFN-beta	B-protein
or	O
IFN-gamma	B-protein
,	O
but	O
not	O
IL-1	B-protein
,	O
IL-2	B-protein
,	O
macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
,	O
granulocyte/macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
,	O
IL-6	B-protein
,	O
or	O
transforming	O
growth	O
factor	O
beta	O
suppressed	O
activation	O
of	O
STAT6	B-protein
by	O
IL-4	B-protein
.	O

This	O
inhibition	O
was	O
associated	O
with	O
decreased	O
tyrosine	O
phosphorylation	O
and	O
nuclear	O
translocation	O
of	O
STAT6	B-protein
and	O
was	O
not	O
evident	O
unless	O
the	O
cells	O
were	O
preincubated	O
with	O
IFN	B-protein
for	O
at	O
least	O
1	O
hr	O
before	O
IL-4	B-protein
stimulation	O
.	O

Furthermore	O
,	O
inhibition	O
by	O
IFN	B-protein
could	O
be	O
blocked	O
by	O
cotreatment	O
with	O
actinomycin	O
D	O
and	O
correlated	O
temporally	O
with	O
induction	O
of	O
the	O
JAK/STAT	B-DNA
inhibitory	I-DNA
gene	I-DNA
,	O
SOCS-1	B-DNA
.	O

Forced	O
expression	O
of	O
SOCS-1	B-DNA
in	O
a	O
macrophage	B-cell_line
cell	I-cell_line
line	I-cell_line
,	O
RAW264	B-cell_line
,	O
markedly	O
suppressed	O
trans-activation	O
of	O
an	O
IL-4-inducible	B-DNA
reporter	I-DNA
as	O
well	O
as	O
IL-6-	O
and	O
IFN-gamma-induced	O
reporter	O
gene	O
activity	O
.	O

These	O
findings	O
demonstrate	O
that	O
IFNs	B-protein
inhibit	O
IL-4	B-protein
-induced	O
activation	O
of	O
STAT6	B-protein
and	O
STAT6	B-protein
-dependent	O
gene	O
expression	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
inducing	O
expression	O
of	O
SOCS-1	B-DNA
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

96	NULL
,	NULL
pp	NULL
.	NULL

10800-10805	NULL
,	NULL
September	NULL
1999	NULL
Immunology	NULL
Interferons	NULL
inhibit	NULL
activation	NULL
of	NULL
STATG6	NULL
by	NULL
interleukin	NULL
4	NULL
in	NULL
human	NULL
monocytes	NULL
by	NULL
inducing	NULL
SOCS-1	NULL
gene	NULL
expression	NULL
HAROLD	NULL
L.	NULL
DICKENSHEETS*	NULL
,	NULL
CHANDRASEKAR	NULL
VENKATARAMANT	NULL
,	NULL
ULRIKE	NULL
SCHINDLERT	NULL
,	NULL
AND	NULL
RayMoND	NULL
P.	NULL
DonnELLy**	NULL
*Division	NULL
of	NULL
Cytokine	NULL
Biology	NULL
,	NULL
Center	NULL
for	NULL
Biologics	NULL
Evaluation	NULL
and	NULL
Research	NULL
,	NULL
Food	NULL
and	NULL
Drug	NULL
Administration	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
;	NULL
and	NULL
TTularik	NULL
,	NULL
Inc.	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
94080	NULL
Edited	NULL
by	NULL
William	NULL
E.	NULL
Paul	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
,	NULL
and	NULL
approved	NULL
July	NULL
8	NULL
,	NULL
1999	NULL
(	NULL
received	NULL
for	NULL
review	NULL
February	NULL
16	NULL
,	NULL
1999	NULL
)	NULL
ABSTRACT	NULL
Interferons	NULL
(	NULL
IFNs	NULL
)	NULL
inhibit	NULL
induction	NULL
by	NULL
IL-4	NULL
of	NULL
multiple	NULL
genes	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
IFNs	NULL
mediate	NULL
this	NULL
inhibition	NULL
has	NULL
not	NULL
been	NULL
defined	NULL
.	NULL

IL-4	NULL
activates	NULL
gene	NULL
expression	NULL
by	NULL
inducing	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
homodimerization	NULL
,	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
the	NULL
latent	NULL
transcription	NULL
factor	NULL
,	NULL
STAT6	NULL
(	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription-6	NULL
)	NULL
.	NULL

STATG6-responsive	NULL
elements	NULL
are	NULL
characteristically	NULL
present	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
IL-4-inducible	NULL
genes	NULL
.	NULL

Because	NULL
STAT6	NULL
activation	NULL
is	NULL
essential	NULL
for	NULL
IL-4-induced	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
IFNs	NULL
to	NULL
regulate	NULL
activation	NULL
of	NULL
STAT6	NULL
by	NULL
IL-4	NULL
in	NULL
primary	NULL
human	NULL
monocytes	NULL
.	NULL

Pretreatment	NULL
of	NULL
monocytes	NULL
with	NULL
IFN-	NULL
or	NULL
IFN-y	NULL
,	NULL
but	NULL
not	NULL
IL-1	NULL
,	NULL
IL-2	NULL
,	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
IL-6	NULL
,	NULL
or	NULL
transforming	NULL
growth	NULL
factor	NULL
B	NULL
suppressed	NULL
activation	NULL
of	NULL
STAT6	NULL
by	NULL
IL-4	NULL
.	NULL

This	NULL
inhibition	NULL
was	NULL
associated	NULL
with	NULL
decreased	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT6	NULL
and	NULL
was	NULL
not	NULL
evident	NULL
unless	NULL
the	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
IFN	NULL
for	NULL
at	NULL
least	NULL
1	NULL
hr	NULL
before	NULL
IL-4	NULL
stimulation	NULL
.	NULL

Furthermore	NULL
,	NULL
inhibition	NULL
by	NULL
IFN	NULL
could	NULL
be	NULL
blocked	NULL
by	NULL
cotreatment	NULL
with	NULL
actinomycin	NULL
D	NULL
and	NULL
correlated	NULL
temporally	NULL
with	NULL
induction	NULL
of	NULL
the	NULL
JAK/STAT	NULL
inhibitory	NULL
gene	NULL
,	NULL
SOCS-1	NULL
.	NULL

Forced	NULL
expression	NULL
of	NULL
SOCS-1	NULL
in	NULL
a	NULL
macrophage	NULL
cell	NULL
line	NULL
,	NULL
RAW264	NULL
,	NULL
markedly	NULL
suppressed	NULL
trans-activation	NULL
of	NULL
an	NULL
IL-4-inducible	NULL
reporter	NULL
as	NULL
well	NULL
as	NULL
IL-6-	NULL
and	NULL
IFN-y-induced	NULL
reporter	NULL
gene	NULL
activity	NULL
.	NULL

These	NULL
findings	NULL
demonstrate	NULL
that	NULL
IFNs	NULL
inhibit	NULL
IL-4-induced	NULL
activation	NULL
of	NULL
STAT6	NULL
and	NULL
STAT6-dependent	NULL
gene	NULL
expression	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
inducing	NULL
expression	NULL
of	NULL
SOCS-1	NULL
.	NULL

The	NULL
Th2-type	NULL
cytokine	NULL
IL-4	NULL
activates	NULL
gene	NULL
expression	NULL
by	NULL
binding	NULL
to	NULL
specific	NULL
receptor	NULL
complexes	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
IL-4-responsive	NULL
target	NULL
cells	NULL
.	NULL

Type	NULL
I	NULL
IL-4	NULL
receptor	NULL
complexes	NULL
are	NULL
heterodimers	NULL
composed	NULL
of	NULL
the	NULL
IL-4Ra	NULL
chain	NULL
(	NULL
p140	NULL
)	NULL
and	NULL
the	NULL
IL-2Ry	NULL
chain	NULL
(	NULL
y	NULL
)	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
IL-4	NULL
to	NULL
these	NULL
receptor	NULL
complexes	NULL
activates	NULL
the	NULL
receptor-associated	NULL
Janus	NULL
tyrosine	NULL
kinases	NULL
,	NULL
JAK1	NULL
and	NULL
JAK3	NULL
,	NULL
which	NULL
then	NULL
phosphorylate	NULL
critical	NULL
tyrosine	NULL
residues	NULL
on	NULL
the	NULL
intracellular	NULL
domain	NULL
(	NULL
ICD	NULL
)	NULL
of	NULL
the	NULL
IL-4Ra	NULL
chain	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

These	NULL
phosphorylated	NULL
tyrosine	NULL
residues	NULL
on	NULL
the	NULL
ICD	NULL
of	NULL
IL-4Ra	NULL
provide	NULL
docking	NULL
sites	NULL
for	NULL
the	NULL
latent	NULL
cytosolic	NULL
transcription	NULL
factor	NULL
,	NULL
STAT6	NULL
(	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription-6	NULL
)	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

STAT6	NULL
binds	NULL
to	NULL
these	NULL
docking	NULL
sites	NULL
via	NULL
its	NULL
SH2	NULL
(	NULL
Sre	NULL
homology	NULL
2	NULL
)	NULL
domain	NULL
and	NULL
is	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
tyrosine-phosphorylated	NULL
by	NULL
the	NULL
receptor-associated	NULL
JAKs	NULL
(	NULL
8-10	NULL
)	NULL
.	NULL

Activated	NULL
STAT6	NULL
then	NULL
homodimerizes	NULL
and	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
where	NULL
it	NULL
binds	NULL
with	NULL
high	NULL
affinity	NULL
to	NULL
STAT	NULL
-binding	NULL
elements	NULL
(	NULL
SBE	NULL
)	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
various	NULL
IL-4	NULL
/IL-13-responsive	NULL
genes	NULL
.	NULL

IL-4	NULL
and	NULL
IL-13	NULL
induce	NULL
transcription	NULL
of	NULL
a	NULL
distinct	NULL
subset	NULL
of	NULL
genes	NULL
in	NULL
human	NULL
monocytes	NULL
,	NULL
including	NULL
FesRIIb	NULL
(	NULL
CD23	NULL
)	NULL
(	NULL
11	NULL
,	NULL
The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

PNAS	NULL
is	NULL
available	NULL
online	NULL
at	NULL
www.pnas.org	NULL
.	NULL

10800	NULL
12	NULL
)	NULL
,	NULL
15-lipoxygenase	NULL
(	NULL
15-LO	NULL
)	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
,	NULL
IL-1	NULL
receptor	NULL
antagonist	NULL
(	NULL
IL-1ra	NULL
)	NULL
(	NULL
15-17	NULL
)	NULL
,	NULL
and	NULL
types	NULL
I	NULL
and	NULL
II	NULL
IL-1	NULL
receptors	NULL
(	NULL
IL-1R	NULL
)	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Type	NULL
I	NULL
IFNs	NULL
(	NULL
IFN-	NULL
«	NULL
and	NULL
IFN-B	NULL
)	NULL
and	NULL
type	NULL
II	NULL
IFN	NULL
(	NULL
IFN-y	NULL
)	NULL
inhibit	NULL
IL-4	NULL
/IL-13-induced	NULL
gene	NULL
expression	NULL
in	NULL
monocytes	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

For	NULL
example	NULL
,	NULL
IFN-y	NULL
suppresses	NULL
IgE	NULL
synthesis	NULL
by	NULL
IL-4-stimulated	NULL
B	NULL
cells	NULL
(	NULL
20-22	NULL
)	NULL
.	NULL

IFNs	NULL
also	NULL
inhibit	NULL
IL-4-induced	NULL
CD23	NULL
expression	NULL
in	NULL
both	NULL
B	NULL
cells	NULL
(	NULL
23	NULL
,	NULL
24	NULL
)	NULL
and	NULL
monocytes	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
IFN-y	NULL
inhibits	NULL
IL-4-	NULL
and	NULL
IL-13-induced	NULL
expression	NULL
of	NULL
15-LO	NULL
and	NULL
IL-1ra	NULL
in	NULL
monocytes	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
recently	NULL
that	NULL
IFN-B	NULL
and	NULL
IFN-y	NULL
inhibit	NULL
expression	NULL
of	NULL
the	NULL
IL-1RI	NULL
and	NULL
IL-1RII	NULL
genes	NULL
in	NULL
IL-4/	NULL
IL-13-stimulated	NULL
monocytes	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
mechanism	NULL
by	NULL
which	NULL
IFNs	NULL
inhibit	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
has	NULL
not	NULL
been	NULL
defined	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
known	NULL
that	NULL
activation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT	NULL
6	NULL
is	NULL
essential	NULL
for	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
by	NULL
IL-4	NULL
and	NULL
IL-13	NULL
(	NULL
29-31	NULL
)	NULL
.	NULL

IL-4/IL-13-response	NULL
elements	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
STAT6-binding	NULL
sites	NULL
)	NULL
are	NULL
present	NULL
in	NULL
the	NULL
proximal	NULL
promoter	NULL
regions	NULL
of	NULL
IL-4	NULL
/IL-13-inducible	NULL
genes	NULL
,	NULL
including	NULL
Is	NULL
(	NULL
32	NULL
)	NULL
,	NULL
IL-1ra	NULL
(	NULL
33	NULL
)	NULL
,	NULL
and	NULL
IL-4Ra	NULL
(	NULL
34	NULL
)	NULL
.	NULL

The	NULL
SBEs	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
these	NULL
genes	NULL
are	NULL
distinct	NULL
from	NULL
classical	NULL
IFN-y	NULL
activation	NULL
sequences	NULL
(	NULL
GAS	NULL
elements	NULL
)	NULL
because	NULL
they	NULL
contain	NULL
an	NULL
intervening	NULL
four-base	NULL
spacer	NULL
instead	NULL
of	NULL
a	NULL
three-base	NULL
spacer	NULL
between	NULL
the	NULL
palindromic	NULL
TTC/GAA	NULL
nucleotides	NULL
.	NULL

This	NULL
difference	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
four-base	NULL
spacer	NULL
instead	NULL
of	NULL
a	NULL
three-base	NULL
spacer	NULL
)	NULL
makes	NULL
these	NULL
SBEs	NULL
very	NULL
selective	NULL
for	NULL
STAT6	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
other	NULL
STAT	NULL
proteins	NULL
such	NULL
as	NULL
STAT1a	NULL
,	NULL
the	NULL
principal	NULL
IFN-inducible	NULL
STAT	NULL
,	NULL
do	NULL
not	NULL
bind	NULL
to	NULL
these	NULL
elements	NULL
and	NULL
can	NULL
not	NULL
compete	NULL
with	NULL
STAT6	NULL
for	NULL
binding	NULL
to	NULL
these	NULL
sites	NULL
.	NULL

Because	NULL
of	NULL
this	NULL
,	NULL
we	NULL
reasoned	NULL
that	NULL
IFNs	NULL
must	NULL
inhibit	NULL
IL-4-inducible	NULL
gene	NULL
expression	NULL
through	NULL
some	NULL
other	NULL
mechanism	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
IFNs	NULL
suppress	NULL
IL-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT	NULL
6	NULL
in	NULL
monocytes	NULL
.	NULL

This	NULL
inhibitory	NULL
effect	NULL
could	NULL
be	NULL
blocked	NULL
by	NULL
actinomycin	NULL
D	NULL
and	NULL
correlated	NULL
temporally	NULL
with	NULL
expression	NULL
of	NULL
the	NULL
JAK/STAT	NULL
inhibitory	NULL
gene	NULL
,	NULL
SOCS-1	NULL
(	NULL
suppressor	NULL
of	NULL
cytokine	NULL
signaling	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
forced	NULL
expression	NULL
of	NULL
SOCS-1	NULL
in	NULL
a	NULL
macrophage	NULL
cell	NULL
line	NULL
,	NULL
RAW264	NULL
,	NULL
markedly	NULL
inhibited	NULL
activation	NULL
of	NULL
an	NULL
IL-4-inducible	NULL
,	NULL
STAT6-responsive	NULL
reporter	NULL
gene	NULL
.	NULL

Thus	NULL
,	NULL
IFNs	NULL
induce	NULL
synthesis	NULL
of	NULL
a	NULL
negative	NULL
regulatory	NULL
factor	NULL
(	NULL
SOCS-1	NULL
)	NULL
that	NULL
can	NULL
suppress	NULL
activation	NULL
of	NULL
STAT6	NULL
.	NULL

These	NULL
findings	NULL
define	NULL
a	NULL
mechanism	NULL
by	NULL
which	NULL
IFNs	NULL
can	NULL
antagonize	NULL
IL-4-	NULL
and	NULL
IL-13-inducible	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

This	NULL
paper	NULL
was	NULL
submitted	NULL
directly	NULL
(	NULL
Track	NULL
II	NULL
)	NULL
to	NULL
the	NULL
Proceedings	NULL
office	NULL
.	NULL

Abbreviations	NULL
:	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility-shift	NULL
assay	NULL
;	NULL
GAS	NULL
,	NULL
y-interferon	NULL
activation	NULL
sequence	NULL
;	NULL
IL-1ra	NULL
,	NULL
IL-1	NULL
receptor	NULL
antagonist	NULL
;	NULL
JAK	NULL
,	NULL
Janus	NULL
kinase	NULL
;	NULL
SBE	NULL
,	NULL
STAT-binding	NULL
element	NULL
;	NULL
SH2	NULL
domain	NULL
,	NULL
Sre	NULL
homology-2	NULL
domain	NULL
;	NULL
SOCS	NULL
,	NULL
suppressor	NULL
of	NULL
cytokine	NULL
signaling	NULL
;	NULL
STAT	NULL
,	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
;	NULL
M-CSF	NULL
,	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
;	NULL
GM-CSF	NULL
,	NULL
granulocyte/macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

#	NULL
To	NULL
whom	NULL
reprint	NULL
requests	NULL
should	NULL
be	NULL
addressed	NULL
at	NULL
:	NULL
Division	NULL
of	NULL
Cytokine	NULL
Biology	NULL
,	NULL
Center	NULL
for	NULL
Biologics	NULL
Evaluation	NULL
and	NULL
Research	NULL
,	NULL
Food	NULL
and	NULL
Drug	NULL
Administration	NULL
,	NULL
HFM-505	NULL
,	NULL
1401	NULL
Rockville	NULL
Pike	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
.	NULL

E-mail	NULL
:	NULL
donnelly	NULL
@	NULL
cber.fda.gov	NULL
.	NULL

Immunology	NULL
:	NULL
Dickenshects	NULL
et	NULL
al	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Culture	NULL
Medium	NULL
and	NULL
Reagents	NULL
.	NULL

The	NULL
complete	NULL
medium	NULL
used	NULL
for	NULL
monocyte	NULL
culture	NULL
consisted	NULL
of	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
GIBCO	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
(	NULL
HyClone	NULL
)	NULL
/2	NULL
mM	NULL
L-glutamine/50	NULL
ug/ml	NULL
gentamycin	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-4	NULL
(	NULL
rhIL-4	NULL
)	NULL
and	NULL
murine	NULL
IL-4	NULL
(	NULL
rmIL-4	NULL
)	NULL
were	NULL
provided	NULL
by	NULL
Schering-Plough	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-13	NULL
was	NULL
obtained	NULL
from	NULL
Bio-Source	NULL
International	NULL
(	NULL
Camarillo	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Recombinant	NULL
human	NULL
IFN-y	NULL
was	NULL
provided	NULL
by	NULL
Genentech	NULL
.	NULL

Recombinant	NULL
human	NULL
IFN-	NULL
was	NULL
provided	NULL
by	NULL
Chiron	NULL
.	NULL

Rabbit	NULL
anti-STAT6	NULL
antibody	NULL
was	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
.	NULL

Rabbit	NULL
anti-phospho	NULL
(	NULL
Tyr®*	NULL
)	NULL
-STAT6	NULL
Ab	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
New	NULL
England	NULL
Biolabs	NULL
.	NULL

Cells	NULL
.	NULL

Normal	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
isolated	NULL
by	NULL
elutriation	NULL
in	NULL
a	NULL
Beckman	NULL
JE-6B	NULL
centrifugal	NULL
elu-triator	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
elutriated	NULL
monocyte	NULL
fraction	NULL
consisted	NULL
of	NULL
>	NULL
95	NULL
%	NULL
monocytes	NULL
as	NULL
determined	NULL
by	NULL
histologic	NULL
staining	NULL
and	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
(	NULL
FACS	NULL
)	NULL
analysis	NULL
with	NULL
the	NULL
anti-CD14	NULL
mAb	NULL
Leu	NULL
M3	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
cultured	NULL
routinely	NULL
at	NULL
4	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
in	NULL
complete	NULL
medium	NULL
in	NULL
round-bottomed	NULL
,	NULL
polypropylene	NULL
tubes	NULL
.	NULL

The	NULL
macrophage	NULL
cell	NULL
line	NULL
,	NULL
RAW264	NULL
,	NULL
was	NULL
obtained	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Manassas	NULL
,	NULL
VA	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
complete	NULL
medium	NULL
.	NULL

Electrophoretic	NULL
Mobility-Shift	NULL
Assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
cytokine-treated	NULL
cells	NULL
by	NULL
using	NULL
a	NULL
modification	NULL
(	NULL
38	NULL
)	NULL
of	NULL
the	NULL
original	NULL
method	NULL
described	NULL
by	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
39	NULL
)	NULL
.	NULL

A	NULL
double-stranded	NULL
oligonucleotide	NULL
(	NULL
IL-1ra	NULL
SBE1	NULL
)	NULL
based	NULL
on	NULL
a	NULL
DNA	NULL
sequence	NULL
present	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
IL-1ra	NULL
gene	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
the	NULL
gel-shift	NULL
assays	NULL
(	NULL
33	NULL
)	NULL
.	NULL

This	NULL
oligonucleotide	NULL
contains	NULL
an	NULL
N4-type	NULL
GAS	NULL
element	NULL
that	NULL
can	NULL
bind	NULL
STAT6	NULL
but	NULL
not	NULL
STAT1a	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
38	NULL
)	NULL
.	NULL

A	NULL
portion	NULL
of	NULL
each	NULL
binding	NULL
reaction	NULL
mixture	NULL
(	NULL
8	NULL
pl	NULL
per	NULL
sample	NULL
)	NULL
was	NULL
electrophoresed	NULL
on	NULL
nondenaturing	NULL
,	NULL
6	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
(	NULL
Novex	NULL
)	NULL
by	NULL
using	NULL
0.25	NULL
%	NULL
TBE	NULL
buffer	NULL
(	NULL
22	NULL
mM	NULL
TrisHCl	NULL
,	NULL
pH	NULL
8.0/22	NULL
mM	NULL
borate	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

The	NULL
gels	NULL
then	NULL
were	NULL
dried	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

Western	NULL
Blots	NULL
.	NULL

After	NULL
cytokine	NULL
treatment	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
Dulbecco	NULL
's	NULL
PBS	NULL
,	NULL
and	NULL
cytosolic	NULL
and	NULL
nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
(	NULL
75	NULL
ug	NULL
per	NULL
sample	NULL
)	NULL
of	NULL
these	NULL
extracts	NULL
were	NULL
resolved	NULL
by	NULL
electrophoresis	NULL
on	NULL
8	NULL
%	NULL
polyacrylamide	NULL
Tris-glycine	NULL
gels	NULL
and	NULL
then	NULL
transferred	NULL
onto	NULL
polyvinylidene	NULL
difluoride	NULL
membranes	NULL
(	NULL
Novex	NULL
)	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
using	NULL
rabbit	NULL
anti-phospho-STAT6	NULL
antibody	NULL
or	NULL
anti-STAT6	NULL
antibody	NULL
at	NULL
a	NULL
final	NULL
dilution	NULL
of	NULL
1:1,000	NULL
in	NULL
TTBS	NULL
containing	NULL
3	NULL
%	NULL
nonfat	NULL
dry	NULL
milk	NULL
(	NULL
TTBs	NULL
=	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.6/137	NULL
mM	NULL
NaQ/0.1	NULL
%	NULL
Tween-20	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
goat	NULL
anti-rabbit	NULL
IgG-horseradish	NULL
peroxidase	NULL
(	NULL
HRP	NULL
)	NULL
(	NULL
Amersham	NULL
)	NULL
diluted	NULL
1:5,000	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
the	NULL
membranes	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
HRP	NULL
substrate	NULL
,	NULL
SuperSignal	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

STAT6	NULL
was	NULL
detected	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
(	NULL
Pierce	NULL
)	NULL
.	NULL

Northern	NULL
Blots	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cultured	NULL
monocytes	NULL
by	NULL
the	NULL
acid/guanidinium	NULL
thiocyanate/phenol/	NULL
chloroform	NULL
extraction	NULL
method	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
RNA	NULL
(	NULL
10	NULL
ug	NULL
per	NULL
lane	NULL
)	NULL
were	NULL
size-fractionated	NULL
by	NULL
electrophoresis	NULL
in	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
containing	NULL
0.66	NULL
M	NULL
formaldehyde	NULL
.	NULL

The	NULL
RNA	NULL
then	NULL
was	NULL
transferred	NULL
onto	NULL
Nytran	NULL
membranes	NULL
and	NULL
cross-linked	NULL
by	NULL
exposure	NULL
to	NULL
UV	NULL
light	NULL
.	NULL

The	NULL
membranes	NULL
then	NULL
were	NULL
hybridized	NULL
and	NULL
washed	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
.	NULL

The	NULL
SOCS-1	NULL
probe	NULL
was	NULL
a	NULL
724-bp	NULL
Xbal	NULL
fragment	NULL
of	NULL
a	NULL
full-length	NULL
murine	NULL
SOCS-1	NULL
cDNA	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Gel-purified	NULL
insert	NULL
DNA	NULL
was	NULL
radiolabeled	NULL
by	NULL
the	NULL
random-primer	NULL
method	NULL
of	NULL
Feinberg	NULL
and	NULL
Vogelstein	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Construction	NULL
of	NULL
the	NULL
SOCS-1	NULL
Expression	NULL
Plasmids	NULL
.	NULL

The	NULL
SOCS-1	NULL
expression	NULL
plasmid	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Hiroyuki	NULL
Mano	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
Flag-tagged	NULL
version	NULL
of	NULL
SOCS-1	NULL
was	NULL
prepared	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
-	NULL
10801	NULL
by	NULL
PCR	NULL
.	NULL

The	NULL
full-length	NULL
cDNA	NULL
was	NULL
amplified	NULL
by	NULL
using	NULL
the	NULL
following	NULL
primers	NULL
:	NULL
5¢-CGC	NULL
GGG	NULL
GGG	NULL
ATC	NULL
CTT	NULL
GTA	NULL
GCA	NULL
CAC	NULL
AAC	NULL
CAG	NULL
GTG	NULL
GCA	NULL
GCC-3	NULL
'	NULL
(	NULL
sense	NULL
)	NULL
and	NULL
5'-GCG	NULL
CCC	NULL
GGA	NULL
ATT	NULL
CGG	NULL
TCA	NULL
AAT	NULL
CTG	NULL
GAA	NULL
GGG	NULL
GAA	NULL
GGA	NULL
GCT	NULL
CAG-3	NULL
'	NULL
(	NULL
antisense	NULL
)	NULL
.	NULL

The	NULL
SOCS-1	NULL
mutant	NULL
,	NULL
bearing	NULL
a	NULL
single	NULL
amino	NULL
acid	NULL
change	NULL
in	NULL
the	NULL
SH2	NULL
domain	NULL
(	NULL
R105A¥	NULL
)	NULL
,	NULL
was	NULL
generated	NULL
by	NULL
using	NULL
two-step	NULL
PCR	NULL
cloning	NULL
and	NULL
the	NULL
following	NULL
primers	NULL
:	NULL
5-GGC	NULL
ACC	NULL
TTC	NULL
CTG	NULL
GTG	NULL
GCC	NULL
GAC	NULL
CAG	NULL
CGG-3	NULL
'	NULL
(	NULL
sense	NULL
)	NULL
and	NULL
5-CCG	NULL
CTG	NULL
GCG	NULL
GCT	NULL
GTC	NULL
GGC	NULL
CAC	NULL
CAG	NULL
GAA	NULL
GGT	NULL
GCC-3	NULL
'	NULL
(	NULL
antisense	NULL
)	NULL
.	NULL

The	NULL
PCR	NULL
products	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
sites	NULL
of	NULL
a	NULL
peDNA3	NULL
derivative	NULL
carrying	NULL
a	NULL
Flag	NULL
epitope	NULL
tag	NULL
.	NULL

The	NULL
integrity	NULL
of	NULL
the	NULL
DNA	NULL
fragments	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequence	NULL
analysis	NULL
.	NULL

Transfections	NULL
.	NULL

The	NULL
IL-4-responsive	NULL
reporter	NULL
construct	NULL
,	NULL
C/EBP-N4	NULL
,	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
IL-4	NULL
response	NULL
element	NULL
in	NULL
this	NULL
construct	NULL
is	NULL
derived	NULL
from	NULL
a	NULL
sequence	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
Ig	NULL
heavy	NULL
chain	NULL
germ-line	NULL
&	NULL
gene	NULL
that	NULL
contains	NULL
adjacent	NULL
binding	NULL
sites	NULL
for	NULL
C/EBP	NULL
and	NULL
STAT6	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Transient	NULL
transfections	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
the	NULL
DEAE-Dextran	NULL
method	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
1	NULL
x	NULL
10°	NULL
RAW264	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
serum-free	NULL
DMEM	NULL
containing	NULL
100	NULL
ug/ml	NULL
DEAE-dextran	NULL
solution	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
IL-4	NULL
luciferase	NULL
reporter	NULL
,	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
the	NULL
SOCS-1	NULL
expression	NULL
plasmids	NULL
(	NULL
wild	NULL
type	NULL
or	NULL
mutant	NULL
)	NULL
or	NULL
vector	NULL
control	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
37°C	NULL
.	NULL

DMSO	NULL
was	NULL
added	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
%	NULL
for	NULL
1	NULL
min	NULL
.	NULL

This	NULL
medium	NULL
then	NULL
was	NULL
washed	NULL
off	NULL
and	NULL
replaced	NULL
with	NULL
fresh	NULL
medium	NULL
.	NULL

Each	NULL
transfection	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
triplicate	NULL
.	NULL

Eighteen	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
ng/ml	NULL
recombinant	NULL
murine	NULL
IL-4	NULL
for	NULL
6	NULL
hr	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
by	NULL
using	NULL
luciferase	NULL
assay	NULL
kits	NULL
obtained	NULL
from	NULL
Promega	NULL
.	NULL

Luciferase	NULL
units	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
amount	NULL
of	NULL
total	NULL
protein	NULL
.	NULL

RESULTS	NULL
IL-4	NULL
Activates	NULL
STAT6	NULL
in	NULL
Human	NULL
Monocytes	NULL
.	NULL

Expression	NULL
of	NULL
IL-4-inducible	NULL
genes	NULL
is	NULL
regulated	NULL
,	NULL
in	NULL
part	NULL
,	NULL
via	NULL
activation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT6	NULL
(	NULL
29-31	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
effects	NULL
of	NULL
IFNs	NULL
on	NULL
STAT6	NULL
activity	NULL
,	NULL
we	NULL
used	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
derived	NULL
from	NULL
a	NULL
DNA	NULL
sequence	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
IL-1	NULL
receptor	NULL
antagonist	NULL
gene	NULL
(	NULL
33	NULL
)	NULL
.	NULL

This	NULL
probe	NULL
,	NULL
denoted	NULL
SBE1	NULL
,	NULL
contains	NULL
a	NULL
GAS-like	NULL
sequence	NULL
that	NULL
binds	NULL
STAT6	NULL
with	NULL
high	NULL
affinity	NULL
,	NULL
but	NULL
does	NULL
not	NULL
bind	NULL
other	NULL
STAT	NULL
proteins	NULL
such	NULL
as	NULL
STAT1a	NULL
or	NULL
STAT3	NULL
(	NULL
33	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
IL-4-stimulated	NULL
monocytes	NULL
generated	NULL
a	NULL
single	NULL
DNA-binding	NULL
complex	NULL
when	NULL
coincubated	NULL
with	NULL
radiolabeled	NULL
SBE1	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
IL-4-inducible	NULL
DNA-binding	NULL
activity	NULL
was	NULL
inhibited	NULL
competitively	NULL
by	NULL
cold	NULL
SBE1	NULL
or	NULL
GRR	NULL
oligonucleotides	NULL
,	NULL
but	NULL
not	NULL
by	NULL
equivalent	NULL
amounts	NULL
of	NULL
NF-KB	NULL
or	NULL
AP-1	NULL
oligonucleotides	NULL
.	NULL

The	NULL
IL-4-inducible	NULL
DNA-binding	NULL
activity	NULL
also	NULL
could	NULL
be	NULL
supershifted	NULL
by	NULL
an	NULL
anti-STAT6	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lane	NULL
14	NULL
)	NULL
but	NULL
not	NULL
by	NULL
an	NULL
anti-STAT1a	NULL
«	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lane	NULL
15	NULL
)	NULL
or	NULL
an	NULL
antibody	NULL
directed	NULL
against	NULL
an	NULL
unrelated	NULL
transcription	NULL
factor	NULL
,	NULL
C/EBP	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
lane	NULL
13	NULL
)	NULL
.	NULL

IFN-B	NULL
and	NULL
IFN-y	NULL
Inhibit	NULL
Activation	NULL
of	NULL
STAT6	NULL
by	NULL
IL-4	NULL
.	NULL

IFN-8	NULL
and	NULL
IFN-y	NULL
inhibit	NULL
induction	NULL
of	NULL
several	NULL
genes	NULL
by	NULL
IL-4	NULL
in	NULL
human	NULL
monocytes	NULL
(	NULL
13	NULL
,	NULL
14	NULL
,	NULL
25-28	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
IFNs	NULL
and/or	NULL
other	NULL
cytokines	NULL
can	NULL
inhibit	NULL
activation	NULL
of	NULL
STAT6	NULL
by	NULL
IL-4	NULL
,	NULL
we	NULL
pretreated	NULL
monocytes	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
37°C	NULL
with	NULL
a	NULL
panel	NULL
of	NULL
cytokines	NULL
that	NULL
included	NULL
IFN-B	NULL
,	NULL
IFN-y	NULL
,	NULL
IL-1	NULL
$	NULL
,	NULL
IL-2	NULL
,	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
M-CSF	NULL
)	NULL
,	NULL
granulocyte/	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
transforming	NULL
growth	NULL
factor	NULL
B	NULL
(	NULL
TGF-	NULL
)	NULL
.	NULL

IL-4	NULL
then	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cultures	NULL
were	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
incubation	NULL
period	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
extracts	NULL
then	NULL
were	NULL
assayed	NULL
for	NULL
STAT6	NULL
activity	NULL
by	NULL
EMSA	NULL
by	NULL
using	NULL
radiolabeled	NULL
IL-1Ra	NULL
SBE1	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
pretreatment	NULL
with	NULL
IFN-	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
IFN-y	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
but	NULL
none	NULL
of	NULL
the	NULL
10802	NULL
_	NULL
Immunology	NULL
:	NULL
Dickenshects	NULL
et	NULL
al	NULL
.	NULL

+	NULL
IL-4	NULL
aim	NULL
+	NULL
IL-4	NULL
a.	NULL
oni	NULL
.	NULL

2	NULL
E	NULL
g	NULL
rt	NULL
=	NULL
ME	NULL
:	NULL
SBE1_	NULL
GAR	NULL
_	NULL
NFxB_	NULL
AP-	NULL
€	NULL
o	NULL
®	NULL
a	NULL
Competitor	NULL
-	NULL
-	NULL
0	NULL
i	NULL
$	NULL
#	NULL
os	NULL
®	NULL
-	NULL
<	NULL
-ss	NULL
wt	NULL
(	NULL
lth	NULL
a	NULL
tah	NULL
twhiul	NULL
=	NULL
Wi	NULL
<	NULL
-stais	NULL
dh	NULL
lh	NULL
ol	NULL
ais	NULL
lh	NULL
lh	NULL
ili	NULL
li	NULL
lth	NULL
als	NULL
a	NULL
10	NULL
2	NULL
%	NULL
4	NULL
5	NULL
6	NULL
7	NULL
B	NULL
#	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

IL-4	NULL
induces	NULL
STAT6	NULL
activity	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
(	NULL
4	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
)	NULL
were	NULL
incubated	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
presence	NULL
{	NULL
Jane	NULL
2	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
of	NULL
recombinant	NULL
human	NULL
IL-4	NULL
(	NULL
rhIL-4	NULL
;	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
cells	NULL
then	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
then	NULL
were	NULL
assayed	NULL
by	NULL
EMSA	NULL
using	NULL
radiolabeled	NULL
IL-1ra	NULL
SBE1	NULL
probe	NULL
.	NULL

In	NULL
lanes	NULL
3-10	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
from	NULL
IL-4-stimulated	NULL
monocytes	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
was	NULL
preincubated	NULL
with	NULL
a	NULL
10-	NULL
or	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
SBE1	NULL
,	NULL
GRR	NULL
,	NULL
NF-kB	NULL
,	NULL
or	NULL
AP-1	NULL
oligonucleotide	NULL
.	NULL

In	NULL
lanes	NULL
11-15	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
the	NULL
nuclear	NULL
extract	NULL
from	NULL
IL-4-stimulated	NULL
monocytes	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
was	NULL
preincubated	NULL
with	NULL
1	NULL
l	NULL
of	NULL
rabbit	NULL
antisera	NULL
specific	NULL
for	NULL
C/EBPB	NULL
,	NULL
STAT6	NULL
,	NULL
or	NULL
STATl	NULL
«	NULL
as	NULL
indicated	NULL
.	NULL

ss	NULL
,	NULL
super	NULL
shift	NULL
.	NULL

other	NULL
cytokines	NULL
tested	NULL
,	NULL
inhibited	NULL
induction	NULL
of	NULL
STAT6	NULL
activity	NULL
by	NULL
IL-4	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
IFN-y	NULL
to	NULL
inhibit	NULL
IL-4-induced	NULL
STAT6	NULL
activity	NULL
was	NULL
dose-dependent	NULL
and	NULL
demonstrable	NULL
when	NULL
IFN-y	NULL
was	NULL
used	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
10	NULL
or	NULL
1	NULL
ng/ml	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
lanes	NULL
11-15	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
STAT6	NULL
Activation	NULL
by	NULL
IFNs	NULL
Is	NULL
Transcription-Dependent	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
inhibition	NULL
by	NULL
IFN	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
gene	NULL
that	NULL
is	NULL
newly	NULL
transcribed	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
actinomycin	NULL
D	NULL
could	NULL
block	NULL
inhibition	NULL
of	NULL
STAT6	NULL
activity	NULL
by	NULL
IFN-y	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
Top	NULL
,	NULL
pretreatment	NULL
with	NULL
IFN-y	NULL
suppressed	NULL
induction	NULL
of	NULL
STAT6	NULL
activity	NULL
by	NULL
IL-4	NULL
in	NULL
control	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
but	NULL
did	NULL
not	NULL
inhibit	NULL
STAT6	NULL
activity	NULL
in	NULL
cells	NULL
that	NULL
were	NULL
cotreated	NULL
with	NULL
actinomycin	NULL
D	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

These	NULL
differences	NULL
were	NULL
even	NULL
more	NULL
apparent	NULL
when	NULL
the	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
protein	NULL
extracts	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
anti-phospho-STAT6	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
Middle	NULL
)	NULL
and	NULL
anti-STAT6	NULL
Abs	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
Bottom	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

Reduced	NULL
STAT6	NULL
DNA-binding	NULL
activity	NULL
was	NULL
associated	NULL
with	NULL
decreased	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT6	NULL
in	NULL
cells	NULL
that	NULL
were	NULL
pretreated	NULL
with	NULL
IFN-y	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
this	NULL
reduction	NULL
+	NULL
IL-4	NULL
+	NULL
IL-4	NULL
E	NULL
1	NULL
T	NULL
1	NULL
%	NULL
IFNy	NULL
&	NULL
$	NULL
s	NULL
ss	NULL
58	NULL
35	NULL
;	NULL
%	NULL
%	NULL
tL	NULL
m.	NULL
%	NULL
§	NULL
P6	NULL
G	NULL
LtG	NULL
G29	NULL
$	NULL
0	NULL
%	NULL
v	NULL
C	NULL
mm	NULL
tuk	NULL
>	NULL
»	NULL
»	NULL
bab	NULL
lak	NULL
ba	NULL
hala	NULL
-	NULL
Wi	NULL
>	NULL
Alig	NULL
)	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
pretreatment	NULL
with	NULL
selected	NULL
cytokines	NULL
on	NULL
induction	NULL
of	NULL
STAT6	NULL
activity	NULL
by	NULL
IL-4	NULL
in	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
(	NULL
4	NULL
X	NULL
108	NULL
cells	NULL
per	NULL
ml	NULL
)	NULL
were	NULL
preincubated	NULL
for	NULL
1	NULL
hr	NULL
at	NULL
37°C	NULL
with	NULL
medium	NULL
alone	NULL
,	NULL
IFN-	NULL
,	NULL
IFN-y	NULL
,	NULL
IL-1	NULL
,	NULL
IL-2	NULL
,	NULL
M-CSF	NULL
,	NULL
GM-CSF	NULL
,	NULL
IL-6	NULL
,	NULL
or	NULL
TGF-B	NULL
(	NULL
10	NULL
ng/ml	NULL
each	NULL
)	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
this	NULL
primary	NULL
incubation	NULL
period	NULL
,	NULL
IL-4	NULL
(	NULL
1	NULL
ng/ml	NULL
)	NULL
was	NULL
added	NULL
(	NULL
lanes	NULL
2-10	NULL
)	NULL
,	NULL
and	NULL
the	NULL
cultures	NULL
were	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
by	NULL
EMSA	NULL
for	NULL
STAT6	NULL
activity	NULL
by	NULL
using	NULL
radiolabeled	NULL
IL-1ra	NULL
SBE1	NULL
probe	NULL
.	NULL

In	NULL
lanes	NULL
11-15	NULL
,	NULL
monocytes	NULL
were	NULL
preincubated	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
lane	NULL
11	NULL
)	NULL
or	NULL
IFN-y	NULL
at	NULL
the	NULL
indicated	NULL
concentrations	NULL
for	NULL
1	NULL
hr	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
this	NULL
initial	NULL
incubation	NULL
period	NULL
,	NULL
IL-4	NULL
(	NULL
1	NULL
ng/ml	NULL
)	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cultures	NULL
were	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
.	NULL

Nuclear	NULL
extracts	NULL
then	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
STAT6	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
+	NULL
Act	NULL
.	NULL

D	NULL
EMSA	NULL
:	NULL
SBE1	NULL
Probe	NULL
It	NULL
io	NULL
Westerns	NULL
:	NULL
kDa	NULL
Nucleus	NULL
sim	NULL
:	NULL
wuss	NULL
98	NULL
--	NULL
<	NULL
-P	NULL
(	NULL
Y	NULL
)	NULL
-Stat6	NULL
Cytosol	NULL
w——————	NULL
--	NULL
‘	NULL
—S|a|ﬁ	NULL
10	NULL
2	NULL
3	NULL
4	NULL
50	NULL
60	NULL
7	NULL
a	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Inhibition	NULL
of	NULL
IL-4-induced	NULL
STAT6	NULL
activity	NULL
by	NULL
IFN-y	NULL
is	NULL
abrogated	NULL
by	NULL
the	NULL
transcription	NULL
inhibitor	NULL
,	NULL
actinomycin	NULL
D.	NULL
Monocytes	NULL
(	NULL
4	NULL
x	NULL
108	NULL
cells	NULL
per	NULL
ml	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
medium	NULL
alone	NULL
or	NULL
IFN-y	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
actinomycin	NULL
D	NULL
(	NULL
Act	NULL
.	NULL

D	NULL
)	NULL
for	NULL
90	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
cells	NULL
then	NULL
were	NULL
treated	NULL
with	NULL
or	NULL
without	NULL
IL-4	NULL
(	NULL
1	NULL
ng/ml	NULL
)	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
second	NULL
incubation	NULL
period	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
STAT6	NULL
activity	NULL
by	NULL
EMSA	NULL
using	NULL
the	NULL
IL-1ra	NULL
SBE1	NULL
probe	NULL
(	NULL
Top	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
protein	NULL
extracts	NULL
also	NULL
were	NULL
analyzed	NULL
by	NULL
immu-noblotting	NULL
with	NULL
rabbit	NULL
anti-P	NULL
(	NULL
Y	NULL
)	NULL
-STAT6	NULL
(	NULL
Middle	NULL
)	NULL
and	NULL
rabbit	NULL
anti-STAT6	NULL
(	NULL
Bottom	NULL
)	NULL
antibodies	NULL
,	NULL
respectively	NULL
.	NULL

did	NULL
not	NULL
occur	NULL
when	NULL
cells	NULL
were	NULL
cotreated	NULL
with	NULL
actinomycin	NULL
D	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Inhibition	NULL
of	NULL
STAT6	NULL
Activity	NULL
by	NULL
IFN	NULL
Is	NULL
Temporally	NULL
Associated	NULL
with	NULL
Expression	NULL
of	NULL
the	NULL
SOCS-1	NULL
Gene	NULL
.	NULL

Temporal	NULL
analysis	NULL
of	NULL
the	NULL
effect	NULL
of	NULL
IFN-y	NULL
on	NULL
IL-4-induced	NULL
STAT6	NULL
activity	NULL
showed	NULL
that	NULL
the	NULL
cells	NULL
need	NULL
to	NULL
be	NULL
preincubated	NULL
with	NULL
IFN	NULL
at	NULL
37°C	NULL
for	NULL
at	NULL
least	NULL
60	NULL
min	NULL
before	NULL
IL-4	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

More	NULL
complete	NULL
inhibition	NULL
was	NULL
attained	NULL
when	NULL
cells	NULL
were	NULL
preincubated	NULL
with	NULL
IFN	NULL
for	NULL
90-120	NULL
min	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
reduced	NULL
STAT6	NULL
DNA-binding	NULL
activity	NULL
was	NULL
associated	NULL
with	NULL
decreased	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT6	NULL
as	NULL
determined	NULL
by	NULL
immunoblot	NULL
analysis	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
protein	NULL
extracts	NULL
using	NULL
rabbit	NULL
anti-P	NULL
(	NULL
Y	NULL
)	NULL
-STAT6	NULL
and	NULL
anti-STAT6	NULL
Abs	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
SOCS	NULL
genes	NULL
constitute	NULL
a	NULL
family	NULL
of	NULL
cytokine-inducible	NULL
,	NULL
SH2-containing	NULL
proteins	NULL
that	NULL
inhibit	NULL
JAK/STAT-dependent	NULL
gene	NULL
expression	NULL
(	NULL
41	NULL
,	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

One	NULL
of	NULL
these	NULL
genes	NULL
,	NULL
SOCS-1	NULL
(	NULL
also	NULL
known	NULL
as	NULL
JAB	NULL
or	NULL
SSI-1	NULL
)	NULL
,	NULL
is	NULL
rapidly	NULL
inducible	NULL
by	NULL
multiple	NULL
cytokines	NULL
,	NULL
including	NULL
type	NULL
I	NULL
and	NULL
II	NULL
IFNs	NULL
,	NULL
in	NULL
the	NULL
leukemic	NULL
murine	NULL
myeloid	NULL
cell	NULL
line	NULL
M1	NULL
(	NULL
41	NULL
,	NULL
47	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
this	NULL
gene	NULL
is	NULL
IFN-inducible	NULL
in	NULL
human	NULL
monocytes	NULL
,	NULL
we	NULL
treated	NULL
monocytes	NULL
with	NULL
IFN-y	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
0-2	NULL
hr	NULL
and	NULL
then	NULL
measured	NULL
SOCS-1	NULL
mRNA	NULL
levels	NULL
by	NULL
Northern	NULL
blotting	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
IFN-y	NULL
induced	NULL
SOCS-1	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Peak	NULL
levels	NULL
of	NULL
SOCS-1	NULL
mRNA	NULL
occurred	NULL
approximately	NULL
90	NULL
min	NULL
posttreat-ment	NULL
.	NULL

The	NULL
appearance	NULL
of	NULL
SOCS-1	NULL
mRNA	NULL
in	NULL
monocytes	NULL
correlated	NULL
temporally	NULL
with	NULL
the	NULL
suppression	NULL
of	NULL
IL-4-induced	NULL
STAT6	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
4	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
analysis	NULL
of	NULL
the	NULL
ability	NULL
of	NULL
multiple	NULL
cytokines	NULL
to	NULL
induce	NULL
SOCS-1	NULL
gene	NULL
expression	NULL
in	NULL
monocytes	NULL
demonstrated	NULL
that	NULL
only	NULL
those	NULL
cytokines	NULL
that	NULL
induced	NULL
SOCS-1	NULL
expression	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
IFN-B	NULL
and	NULL
IFN-y	NULL
)	NULL
inhibited	NULL
IL-4-induced	NULL
activation	NULL
of	NULL
STAT6	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
forced	NULL
expression	NULL
of	NULL
the	NULL
SOCS-1	NULL
gene	NULL
in	NULL
a	NULL
myeloid	NULL
cell	NULL
line	NULL
can	NULL
suppress	NULL
IL-4-inducible	NULL
promoter	NULL
activity	NULL
,	NULL
we	NULL
transfected	NULL
the	NULL
macrophage	NULL
cell	NULL
line	NULL
,	NULL
RAW264	NULL
,	NULL
with	NULL
an	NULL
IL-4-inducible	NULL
reporter	NULL
gene	NULL
,	NULL
C/EBP-N4	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
a	NULL
wild-type	NULL
or	NULL
mutant	NULL
SOCS-1	NULL
expression	NULL
plasmid	NULL
.	NULL

We	NULL
then	NULL
measured	NULL
reporter	NULL
gene	NULL
activity	NULL
6	NULL
hr	NULL
after	NULL
stimulating	NULL
these	NULL
cells	NULL
with	NULL
IL-4	NULL
.	NULL

The	NULL
reporter	NULL
gene	NULL
used	NULL
to	NULL
assess	NULL
IL-4	NULL
responsiveness	NULL
contains	NULL
a	NULL
prototypical	NULL
N4	NULL
STAT6-binding	NULL
site	NULL
(	NULL
44	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

64	NULL
,	NULL
IL-4	NULL
induction	NULL
of	NULL
control	NULL
RAW264	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
reporter	NULL
gene	NULL
alone	NULL
resulted	NULL
in	NULL
a	NULL
42-fold	NULL
increase	NULL
in	NULL
basal	NULL
luciferase	NULL
activity	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
these	NULL
levels	NULL
were	NULL
diminished	NULL
markedly	NULL
(	NULL
~84	NULL
%	NULL
Immunology	NULL
:	NULL
Dickenshects	NULL
et	NULL
al	NULL
.	NULL

A	NULL
.	NULL

+	NULL
IL-4	NULL
-	NULL
1	NULL
e	NULL
IFN-y	NULL
Medium	NULL
E	NULL
Fo	NULL
o	NULL
r	NULL
~	NULL
b	NULL
EMSA	NULL
:	NULL
6	NULL
a	NULL
8	NULL
§	NULL
8	NULL
®	NULL
»	NULL
8	NULL
8	NULL
§	NULL
®	NULL
time	NULL
(	NULL
min	NULL
)	NULL
SBE	NULL
1	NULL
Probe	NULL
dul	NULL
to	NULL
i-	NULL
dud	NULL
lak	NULL
tut	NULL
tad	NULL
bot	NULL
<	NULL
--	NULL
State	NULL
B	NULL
.	NULL

+	NULL
IL-4	NULL
~a	NULL
6	NULL
IFN-y	NULL
Medium	NULL
Western	NULL
biot	NULL
:	NULL
‘	NULL
g	NULL
'	NULL
Lok	NULL
.	NULL

e	NULL
``	NULL
wos	NULL
,	NULL
RI	NULL
0	NULL
s	NULL
8	NULL
$	NULL
&	NULL
``	NULL
os	NULL
8	NULL
§	NULL
%	NULL
®	NULL
time	NULL
(	NULL
min	NULL
)	NULL
Nucleus	NULL
:	NULL
116-97.	NULL
woes	NULL
ems	NULL
sue	NULL
wou	NULL
coms	NULL
cuse	NULL
sume	NULL
-4—P	NULL
(	NULL
Y	NULL
)	NULL
‘	NULL
STHT6	NULL
Cytosol	NULL
:	NULL
-	NULL
116	NULL
:	NULL
g	NULL
?	NULL

_-—-———	NULL
--	NULL
—-—*	NULL
“	NULL
Stat6	NULL
10	NULL
2	NULL
3	NULL
4	NULL
§	NULL
60	NULL
7	NULL
8	NULL
9	NULL
1:0	NULL
11	NULL
C.	NULL
IFN-y	NULL
0	NULL
30°	NULL
60°	NULL
90°	NULL
120°	NULL
»	NULL
*	NULL
~SOCS-1	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Kinetic	NULL
analysis	NULL
of	NULL
the	NULL
induction	NULL
of	NULL
inhibition	NULL
by	NULL
IFN-y	NULL
in	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
(	NULL
4	NULL
X	NULL
108	NULL
cells	NULL
per	NULL
ml	NULL
)	NULL
were	NULL
preincubated	NULL
with	NULL
IFN-y	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

(	NULL
lanes	NULL
2-6	NULL
)	NULL
or	NULL
medium	NULL
(	NULL
lanes	NULL
7-11	NULL
)	NULL
for	NULL
0	NULL
,	NULL
30	NULL
,	NULL
60	NULL
,	NULL
90	NULL
,	NULL
or	NULL
120	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

IL-4	NULL
(	NULL
1	NULL
ng/ml	NULL
)	NULL
then	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
cultures	NULL
were	NULL
incubated	NULL
for	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
.	NULL

Nuclear	NULL
extracts	NULL
then	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
by	NULL
EMSA	NULL
for	NULL
STAT6	NULL
activity	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
nuclear	NULL
and	NULL
cytosolic	NULL
protein	NULL
fractions	NULL
also	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
anti-P	NULL
(	NULL
Y	NULL
)	NULL
-STAT6	NULL
and	NULL
anti-STAT6	NULL
antibodies	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Monocytes	NULL
were	NULL
incubated	NULL
with	NULL
rhIFN-y	NULL
for	NULL
0-2	NULL
hr	NULL
at	NULL
37°C	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
time	NULL
points	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
isolated	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
SOCS-1	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
mRNA	NULL
then	NULL
were	NULL
examined	NULL
by	NULL
Northern	NULL
blotting	NULL
.	NULL

suppression	NULL
)	NULL
in	NULL
cells	NULL
that	NULL
were	NULL
cotransfected	NULL
with	NULL
the	NULL
reporter	NULL
gene	NULL
plus	NULL
the	NULL
wild-type	NULL
SOCS-1	NULL
expression	NULL
plasmid	NULL
.	NULL

The	NULL
SOCS	NULL
proteins	NULL
contain	NULL
central	NULL
SH2	NULL
domains	NULL
that	NULL
enable	NULL
them	NULL
to	NULL
bind	NULL
to	NULL
phosphorylated	NULL
tyrosine	NULL
residues	NULL
on	NULL
the	NULL
intracellular	NULL
domains	NULL
of	NULL
cytokine	NULL
receptors	NULL
or	NULL
the	NULL
receptor-associated	NULL
JAKs	NULL
(	NULL
41	NULL
,	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

These	NULL
SH2	NULL
domains	NULL
appear	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
the	NULL
biological	NULL
activity	NULL
of	NULL
the	NULL
SOCS	NULL
proteins	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
the	NULL
SOCS-1	NULL
SH2	NULL
domain	NULL
in	NULL
mediating	NULL
inhibition	NULL
of	NULL
IL-4-induced	NULL
reporter	NULL
gene	NULL
activity	NULL
,	NULL
we	NULL
introduced	NULL
an	NULL
Arg	NULL
-	NULL
>	NULL
Ala	NULL
Control	NULL
IFN-B	NULL
IFN-y	NULL
IL-18	NULL
IL-2	NULL
M-CSF	NULL
GM-CSF	NULL
IL-6	NULL
TGF-B	NULL
w	NULL
t	NULL
t	NULL
t	NULL
«	NULL
SOCS-1	NULL
tae	NULL
tut	NULL
tort	NULL
tut	NULL
tae	NULL
bud	NULL
dud	NULL
tut	NULL
#	NULL
#	NULL
-GAPDH	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
ability	NULL
of	NULL
multiple	NULL
cytokines	NULL
to	NULL
induce	NULL
SOCS-1	NULL
gene	NULL
expression	NULL
in	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
(	NULL
4	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
)	NULL
were	NULL
cultured	NULL
at	NULL
37°C	NULL
for	NULL
2	NULL
hr	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
medium	NULL
alone	NULL
,	NULL
IFN-8	NULL
,	NULL
IFN-y	NULL
,	NULL
IL-1	NULL
,	NULL
IL-2	NULL
,	NULL
M-CSF	NULL
,	NULL
GM-CSF	NULL
,	NULL
IL-6	NULL
,	NULL
or	NULL
(	NULL
10	NULL
ng/ml	NULL
each	NULL
)	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
incubation	NULL
period	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
,	NULL
RNA	NULL
was	NULL
extracted	NULL
,	NULL
and	NULL
SOCS-1	NULL
mRNA	NULL
levels	NULL
were	NULL
measured	NULL
by	NULL
Northern	NULL
blotting	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
-	NULL
10803	NULL
A.	NULL
C+	NULL
Vector	NULL
8	NULL
{	NULL
m+	NULL
SOCS-1	NULL
A+	NULL
mut	NULL
.	NULL

SOCS-1	NULL
Luciferase	NULL
Activity	NULL
1.8	NULL
B.	NULL
O+	NULL
Vector	NULL
1.6	NULL
|m+	NULL
SOCS-1	NULL
&	NULL
+	NULL
mut	NULL
.	NULL

SOCS-1	NULL
0.8	NULL
0.6	NULL
Luciferase	NULL
Activity	NULL
0.4	NULL
0.2	NULL
0	NULL
tL-6	NULL
:	NULL
-	NULL
+	NULL
+	NULL
+	NULL
20	NULL
o	NULL
D+	NULL
Vector	NULL
18	NULL
{	NULL
m+	NULL
SOCS-1	NULL
+	NULL
mut	NULL
.	NULL

SOCS-1	NULL
Luciferase	NULL
Activity	NULL
3	NULL
o	NULL
n	NULL
a	NULL
o	NULL
o	NULL
IFN-y	NULL
-	NULL
+	NULL
+	NULL
+	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

(	NULL
4	NULL
)	NULL
Forced	NULL
expression	NULL
of	NULL
SOCS-1	NULL
in	NULL
the	NULL
macrophage	NULL
cell	NULL
line	NULL
,	NULL
RAW264	NULL
,	NULL
inhibits	NULL
IL-4-induced	NULL
trans-activation	NULL
of	NULL
a	NULL
STAT6-responsive	NULL
reporter	NULL
gene	NULL
.	NULL

RAW264	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
an	NULL
IL-4-inducible	NULL
reporter	NULL
,	NULL
C/EBP-N4-Luc	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
a	NULL
wild-type	NULL
SOCS-1	NULL
expression	NULL
plasmid	NULL
or	NULL
a	NULL
SOCS-1	NULL
mutant	NULL
(	NULL
mut	NULL
.	NULL

SOCS-1	NULL
)	NULL
containing	NULL
a	NULL
single	NULL
amino	NULL
acid	NULL
change	NULL
(	NULL
Arg	NULL
!	NULL
``	NULL

-	NULL
>	NULL
Ala	NULL
)	NULL
in	NULL
the	NULL
SH2	NULL
domain	NULL
.	NULL

Control	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
reporter	NULL
gene	NULL
plus	NULL
the	NULL
plasmid	NULL
vector	NULL
alone	NULL
.	NULL

Eighteen	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
recombinant	NULL
murine	NULL
IL-4	NULL
(	NULL
rmIL-4	NULL
;	NULL
10	NULL
ng/ml	NULL
)	NULL
for	NULL
6	NULL
hr	NULL
.	NULL

Luciferase	NULL
activity	NULL
then	NULL
was	NULL
measured	NULL
and	NULL
normalized	NULL
to	NULL
total	NULL
protein	NULL
.	NULL

Values	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Forced	NULL
expression	NULL
of	NULL
SOCS-1	NULL
in	NULL
RAW264	NULL
cells	NULL
inhibits	NULL
IL-6-induced	NULL
trans-activation	NULL
of	NULL
a	NULL
STAT	NULL
reporter	NULL
,	NULL
IRF-1-Luc	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Forced	NULL
expression	NULL
of	NULL
§OCS-1	NULL
in	NULL
RAW	NULL
264	NULL
cells	NULL
inhibits	NULL
IFN-y-induced	NULL
trans-activation	NULL
of	NULL
a	NULL
STAT	NULL
reporter	NULL
(	NULL
IRF-1-Luc	NULL
)	NULL
.	NULL

mutation	NULL
in	NULL
the	NULL
phosphotyrosine-binding	NULL
pocket	NULL
of	NULL
the	NULL
SOCS-1	NULL
SH2	NULL
domain	NULL
.	NULL

This	NULL
mutation	NULL
abrogated	NULL
the	NULL
ability	NULL
of	NULL
SOCS-1	NULL
to	NULL
inhibit	NULL
IL-4-induced	NULL
reporter	NULL
gene	NULL
activity	NULL
in	NULL
RAW264	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
forced	NULL
expression	NULL
of	NULL
SOCS-1	NULL
in	NULL
RAW264	NULL
cells	NULL
also	NULL
inhibits	NULL
activation	NULL
by	NULL
other	NULL
cytokines	NULL
that	NULL
utilize	NULL
the	NULL
JAK	NULL
/STAT	NULL
signaling	NULL
pathway	NULL
,	NULL
we	NULL
cotransfected	NULL
the	NULL
SOCS-1	NULL
expression	NULL
construct	NULL
together	NULL
with	NULL
a	NULL
reporter	NULL
gene	NULL
(	NULL
IRF-1-Luc	NULL
)	NULL
that	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
either	NULL
IL-6	NULL
or	NULL
IFN-y	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
B	NULL
and	NULL
C	NULL
,	NULL
SOCS-1	NULL
markedly	NULL
inhibited	NULL
trans-	NULL
10804	NULL
_	NULL
Immunology	NULL
:	NULL
Dickenshects	NULL
et	NULL
al	NULL
.	NULL

activation	NULL
of	NULL
this	NULL
reporter	NULL
gene	NULL
by	NULL
both	NULL
IL-6	NULL
and	NULL
IFN-y	NULL
.	NULL

Therefore	NULL
,	NULL
once	NULL
expressed	NULL
,	NULL
SOCS-1	NULL
can	NULL
inhibit	NULL
signal	NULL
trans-duction	NULL
mediated	NULL
via	NULL
multiple	NULL
cytokine	NULL
receptors	NULL
.	NULL

DISCUSSION	NULL
Type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
IFNs	NULL
inhibit	NULL
expression	NULL
of	NULL
several	NULL
IL-4/	NULL
IL-13-inducible	NULL
genes	NULL
in	NULL
monocytes	NULL
,	NULL
including	NULL
CD23	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
,	NULL
15-lipoxygenase	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
,	NULL
IL-1ra	NULL
(	NULL
27	NULL
)	NULL
,	NULL
IL-1RI	NULL
,	NULL
and	NULL
IL-1RIH	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
promoter	NULL
regions	NULL
of	NULL
these	NULL
genes	NULL
contain	NULL
functional	NULL
STAT6-binding	NULL
sites	NULL
through	NULL
which	NULL
IL-4	NULL
and	NULL
IL-13	NULL
induce	NULL
(	NULL
or	NULL
amplify	NULL
)	NULL
their	NULL
expression	NULL
.	NULL

The	NULL
present	NULL
studies	NULL
were	NULL
conducted	NULL
to	NULL
determine	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
by	NULL
which	NULL
IFNs	NULL
suppress	NULL
IL-4-and	NULL
IL-13-inducible	NULL
gene	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
monocytes	NULL
.	NULL

We	NULL
found	NULL
that	NULL
pretreatment	NULL
of	NULL
monocytes	NULL
with	NULL
type	NULL
I	NULL
or	NULL
II	NULL
IFNs	NULL
inhibits	NULL
IL-4-induced	NULL
activation	NULL
and	NULL
nuclear	NULL
translocation	NULL
of	NULL
STAT6	NULL
.	NULL

Inhibition	NULL
of	NULL
STAT6	NULL
activation	NULL
required	NULL
preincubation	NULL
with	NULL
IFN	NULL
for	NULL
at	NULL
least	NULL
1	NULL
hr	NULL
and	NULL
could	NULL
be	NULL
blocked	NULL
by	NULL
actinomycin	NULL
D.	NULL
Furthermore	NULL
,	NULL
the	NULL
onset	NULL
of	NULL
inhibition	NULL
correlated	NULL
temporally	NULL
with	NULL
expression	NULL
of	NULL
the	NULL
JAK/STAT	NULL
inhibitory	NULL
gene	NULL
,	NULL
SOCS-1	NULL
.	NULL

Moreover	NULL
,	NULL
forced	NULL
expression	NULL
of	NULL
SOCS-1	NULL
in	NULL
the	NULL
macrophage	NULL
cell	NULL
line	NULL
,	NULL
RAW264	NULL
,	NULL
markedly	NULL
suppressed	NULL
IL-4-induced	NULL
trans-activation	NULL
of	NULL
a	NULL
STAT6-dependent	NULL
reporter	NULL
gene	NULL
.	NULL

These	NULL
findings	NULL
define	NULL
a	NULL
mechanism	NULL
by	NULL
which	NULL
IFNs	NULL
may	NULL
suppress	NULL
expression	NULL
of	NULL
multiple	NULL
IL-4	NULL
genes	NULL
.	NULL

A	NULL
family	NULL
of	NULL
genes	NULL
known	NULL
as	NULL
the	NULL
SOCS	NULL
or	NULL
SSI	NULL
(	NULL
STAT	NULL
-induced	NULL
STAT	NULL
inhibitor	NULL
)	NULL
genes	NULL
recently	NULL
has	NULL
been	NULL
identified	NULL
(	NULL
41	NULL
,	NULL
45	NULL
,	NULL
46	NULL
)	NULL
.	NULL

The	NULL
proteins	NULL
encoded	NULL
by	NULL
these	NULL
genes	NULL
are	NULL
relatively	NULL
small	NULL
molecules	NULL
(	NULL
20-40	NULL
kDa	NULL
)	NULL
that	NULL
can	NULL
interact	NULL
physically	NULL
via	NULL
their	NULL
central	NULL
SH2	NULL
domains	NULL
with	NULL
either	NULL
phosphotyrosine	NULL
residues	NULL
in	NULL
the	NULL
JAK	NULL
kinases	NULL
and/or	NULL
the	NULL
intracellular	NULL
domains	NULL
of	NULL
certain	NULL
cytokine	NULL
receptors	NULL
and	NULL
,	NULL
thereby	NULL
,	NULL
inhibit	NULL
cytokine-induced	NULL
STAT	NULL
activation	NULL
and	NULL
STAT-dependent	NULL
gene	NULL
expression	NULL
.	NULL

We	NULL
considered	NULL
whether	NULL
inhibition	NULL
of	NULL
IL-4-induced	NULL
STAT6	NULL
activity	NULL
by	NULL
IFNs	NULL
might	NULL
be	NULL
mediated	NULL
via	NULL
the	NULL
induction	NULL
of	NULL
one	NULL
or	NULL
more	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
SOCS-1	NULL
expression	NULL
in	NULL
the	NULL
leukemic	NULL
murine	NULL
myeloid	NULL
cell	NULL
line	NULL
M1	NULL
can	NULL
be	NULL
markedly	NULL
up-regulated	NULL
by	NULL
treatment	NULL
with	NULL
various	NULL
cytokines	NULL
,	NULL
including	NULL
IFNs	NULL
(	NULL
47	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
both	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
IFNs	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
SOCS-1	NULL
expression	NULL
in	NULL
murine	NULL
bone	NULL
marrow	NULL
stem	NULL
cells	NULL
(	NULL
41	NULL
)	NULL
.	NULL

However	NULL
,	NULL
to	NULL
date	NULL
,	NULL
no	NULL
published	NULL
studies	NULL
have	NULL
examined	NULL
whether	NULL
IFNs	NULL
can	NULL
induce	NULL
SOCS	NULL
gene	NULL
expression	NULL
in	NULL
primary	NULL
human	NULL
cells	NULL
.	NULL

We	NULL
found	NULL
that	NULL
IFN	NULL
treatment	NULL
induces	NULL
high	NULL
levels	NULL
of	NULL
SOCS-1	NULL
expression	NULL
in	NULL
monocytes	NULL
and	NULL
that	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
coincides	NULL
with	NULL
decreased	NULL
STAT6	NULL
activity	NULL
.	NULL

Inhibition	NULL
of	NULL
STAT6	NULL
activity	NULL
by	NULL
IFNs	NULL
required	NULL
that	NULL
the	NULL
cells	NULL
be	NULL
preincubated	NULL
with	NULL
IFN-	NULL
or	NULL
IFN-y	NULL
for	NULL
at	NULL
least	NULL
60	NULL
min	NULL
before	NULL
IL-4	NULL
stimulation	NULL
.	NULL

More	NULL
complete	NULL
suppression	NULL
was	NULL
attained	NULL
when	NULL
monocytes	NULL
were	NULL
preincubated	NULL
with	NULL
IFN	NULL
for	NULL
90-120	NULL
min	NULL
.	NULL

This	NULL
lag	NULL
period	NULL
appears	NULL
to	NULL
be	NULL
necessary	NULL
for	NULL
de	NULL
novo	NULL
expression	NULL
of	NULL
SOCS-1	NULL
.	NULL

Inhibition	NULL
could	NULL
be	NULL
blocked	NULL
by	NULL
actinomycin	NULL
D	NULL
,	NULL
demonstrating	NULL
that	NULL
it	NULL
is	NULL
newly	NULL
transcribed	NULL
.	NULL

In	NULL
normal	NULL
resting	NULL
cells	NULL
,	NULL
the	NULL
SOCS	NULL
proteins	NULL
do	NULL
not	NULL
exist	NULL
as	NULL
preformed	NULL
latent	NULL
molecules	NULL
in	NULL
the	NULL
cytosol	NULL
.	NULL

However	NULL
,	NULL
their	NULL
expression	NULL
can	NULL
be	NULL
induced	NULL
rapidly	NULL
by	NULL
multiple	NULL
cytokines	NULL
,	NULL
including	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
IFNs	NULL
(	NULL
41	NULL
,	NULL
47	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
IFN-8	NULL
and	NULL
IFN-y	NULL
induce	NULL
high	NULL
levels	NULL
of	NULL
SOCS-1	NULL
expression	NULL
in	NULL
monocytes	NULL
and	NULL
that	NULL
induction	NULL
of	NULL
SOCS-1	NULL
mRNA	NULL
coincides	NULL
with	NULL
the	NULL
suppression	NULL
of	NULL
IL-4-induced	NULL
STAT6	NULL
activity	NULL
.	NULL

Other	NULL
cytokines	NULL
such	NULL
as	NULL
IL-1	NULL
,	NULL
IL-2	NULL
,	NULL
M-CSF	NULL
,	NULL
GM-CSF	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TGF-B	NULL
did	NULL
not	NULL
induce	NULL
SOCS-1	NULL
mRNA	NULL
and	NULL
did	NULL
not	NULL
inhibit	NULL
IL-4-induced	NULL
activation	NULL
of	NULL
STAT6	NULL
.	NULL

Forced	NULL
expression	NULL
of	NULL
the	NULL
SOCS-1	NULL
gene	NULL
in	NULL
the	NULL
macrophage	NULL
cell	NULL
line	NULL
,	NULL
RAW264	NULL
,	NULL
markedly	NULL
inhibited	NULL
IL-4-induced	NULL
trans-activation	NULL
of	NULL
a	NULL
STAT6-responsive	NULL
reporter	NULL
gene	NULL
.	NULL

Thus	NULL
,	NULL
IFNs	NULL
inhibit	NULL
IL-4-induced	NULL
STAT6	NULL
activity	NULL
and	NULL
STAT6-dependent	NULL
gene	NULL
expression	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
inducing	NULL
SOCS-1	NULL
gene	NULL
expression	NULL
.	NULL

Although	NULL
preincubation	NULL
of	NULL
monocytes	NULL
with	NULL
IFNs	NULL
suppressed	NULL
IL-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT6	NULL
,	NULL
decreased	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
STAT6	NULL
phosphorylation	NULL
actually	NULL
may	NULL
be	NULL
a	NULL
secondary	NULL
consequence	NULL
of	NULL
decreased	NULL
JAK1	NULL
activity	NULL
.	NULL

JAK1	NULL
is	NULL
constitutively	NULL
associated	NULL
with	NULL
the	NULL
intracellular	NULL
domain	NULL
of	NULL
the	NULL
IL-4Ra	NULL
«	NULL
chain	NULL
in	NULL
both	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
IL-4R	NULL
complexes	NULL
,	NULL
and	NULL
both	NULL
IL-4	NULL
and	NULL
IL-13	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK1	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
JAK1-deficient	NULL
cell	NULL
lines	NULL
are	NULL
unable	NULL
to	NULL
transduce	NULL
IL-4-mediated	NULL
signals	NULL
(	NULL
5	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
precise	NULL
mechanism	NULL
by	NULL
which	NULL
SOCS	NULL
proteins	NULL
inhibit	NULL
cytokine-induced	NULL
signaling	NULL
has	NULL
not	NULL
been	NULL
fully	NULL
defined	NULL
,	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
SOCS-1	NULL
can	NULL
bind	NULL
via	NULL
its	NULL
SH2	NULL
domain	NULL
to	NULL
the	NULL
tyrosine	NULL
kinase	NULL
domain	NULL
(	NULL
JH1	NULL
domain	NULL
)	NULL
in	NULL
all	NULL
four	NULL
JAKs	NULL
and	NULL
,	NULL
thereby	NULL
,	NULL
inhibit	NULL
their	NULL
activity	NULL
(	NULL
45-47	NULL
)	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
IFN-induced	NULL
SOCS-1	NULL
targets	NULL
primarily	NULL
JAK1	NULL
and	NULL
that	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
6	NULL
is	NULL
decreased	NULL
only	NULL
as	NULL
a	NULL
secondary	NULL
consequence	NULL
of	NULL
decreased	NULL
activation	NULL
of	NULL
JAK1	NULL
.	NULL

Unfortunately	NULL
,	NULL
IFN-B	NULL
and	NULL
IFN-y	NULL
themselves	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK1	NULL
,	NULL
so	NULL
it	NULL
is	NULL
difficult	NULL
to	NULL
determine	NULL
directly	NULL
whether	NULL
IL-4-induced	NULL
JAK1	NULL
activity	NULL
is	NULL
decreased	NULL
in	NULL
IFN-treated	NULL
monocytes	NULL
because	NULL
the	NULL
basal	NULL
levels	NULL
of	NULL
tyrosine-phosphorylated	NULL
JAK1	NULL
are	NULL
elevated	NULL
significantly	NULL
by	NULL
IFN	NULL
pretreatment	NULL
.	NULL

However	NULL
,	NULL
a	NULL
recent	NULL
report	NULL
showed	NULL
that	NULL
stable	NULL
expression	NULL
of	NULL
SOCS-1	NULL
in	NULL
the	NULL
murine	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
M12	NULL
,	NULL
markedly	NULL
inhibits	NULL
IL-4-induced	NULL
activation	NULL
of	NULL
JAK1	NULL
(	NULL
49	NULL
)	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
IFNs	NULL
to	NULL
antagonize	NULL
IL-4-	NULL
or	NULL
IL-13-induced	NULL
STAT6	NULL
activity	NULL
is	NULL
not	NULL
limited	NULL
to	NULL
monocytes	NULL
because	NULL
we	NULL
have	NULL
found	NULL
that	NULL
IFN-B	NULL
and	NULL
IFN-y	NULL
also	NULL
inhibit	NULL
activation	NULL
of	NULL
STAT6	NULL
in	NULL
fibroblasts	NULL
.	NULL

These	NULL
findings	NULL
demonstrate	NULL
that	NULL
this	NULL
inhibitory	NULL
pathway	NULL
is	NULL
inducible	NULL
in	NULL
both	NULL
hematopoietic	NULL
and	NULL
nonhemato-poictic	NULL
cells	NULL
and	NULL
may	NULL
be	NULL
a	NULL
common	NULL
mechanism	NULL
by	NULL
which	NULL
IFNs	NULL
can	NULL
antagonize	NULL
IL-4-	NULL
and	NULL
IL-13-induced	NULL
signaling	NULL
in	NULL
multiple	NULL
cell	NULL
types	NULL
.	NULL

Studies	NULL
have	NULL
shown	NULL
that	NULL
IFN-y	NULL
can	NULL
inhibit	NULL
IL-4-induced	NULL
proliferation	NULL
by	NULL
Th2-type	NULL
T	NULL
cell	NULL
clones	NULL
(	NULL
50	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
number	NULL
of	NULL
earlier	NULL
reports	NULL
showed	NULL
that	NULL
pretreatment	NULL
of	NULL
primary	NULL
B	NULL
cells	NULL
or	NULL
B	NULL
cell	NULL
lines	NULL
with	NULL
type	NULL
I	NULL
or	NULL
II	NULL
IFNs	NULL
inhibits	NULL
IL-4-induced	NULL
Ig	NULL
isotype	NULL
switching	NULL
to	NULL
IgE	NULL
(	NULL
20-22	NULL
)	NULL
.	NULL

A	NULL
functional	NULL
STAT6-binding	NULL
site	NULL
is	NULL
present	NULL
in	NULL
the	NULL
proximal	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
Is	NULL
gene	NULL
,	NULL
and	NULL
binding	NULL
of	NULL
activated	NULL
STAT6	NULL
to	NULL
this	NULL
site	NULL
is	NULL
essential	NULL
for	NULL
IL-4-induced	NULL
gene	NULL
expression	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
recent	NULL
studies	NULL
show	NULL
that	NULL
IFN-y	NULL
also	NULL
inhibits	NULL
activation	NULL
of	NULL
STAT6	NULL
in	NULL
certain	NULL
B	NULL
cell	NULL
lines	NULL
(	NULL
49	NULL
,	NULL
51	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
this	NULL
is	NULL
also	NULL
a	NULL
mechanism	NULL
by	NULL
which	NULL
IFNs	NULL
inhibit	NULL
IgE	NULL
synthesis	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Further	NULL
characterization	NULL
of	NULL
the	NULL
molecular	NULL
basis	NULL
by	NULL
which	NULL
IFNs	NULL
inhibit	NULL
STAT	NULL
6	NULL
activity	NULL
may	NULL
aid	NULL
in	NULL
the	NULL
future	NULL
development	NULL
of	NULL
specific	NULL
inhibitors	NULL
of	NULL
STAT	NULL
6	NULL
.	NULL

Such	NULL
compounds	NULL
might	NULL
be	NULL
very	NULL
useful	NULL
as	NULL
therapeutic	NULL
agents	NULL
for	NULL
treating	NULL
diseases	NULL
characterized	NULL
by	NULL
elevated	NULL
IL-4	NULL
and	NULL
IL-13	NULL
levels	NULL
,	NULL
particularly	NULL
atopic	NULL
disorders	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
supported	NULL
by	NULL
recent	NULL
reports	NULL
showing	NULL
that	NULL
STAT6	NULL
knock-out	NULL
mice	NULL
are	NULL
highly	NULL
resistant	NULL
to	NULL
bronchoalveolar	NULL
challenge	NULL
with	NULL
allergens	NULL
that	NULL
are	NULL
known	NULL
to	NULL
induce	NULL
IL-4	NULL
and	NULL
IL-13	NULL
activity	NULL
(	NULL
52	NULL
,	NULL
53	NULL
)	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
a	NULL
recent	NULL
study	NULL
showed	NULL
that	NULL
thymocytes	NULL
from	NULL
SOCS-1	NULL
knock-out	NULL
mice	NULL
exhibit	NULL
exaggerated	NULL
IL-4-induced	NULL
STAT6	NULL
activity	NULL
(	NULL
54	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
as	NULL
well	NULL
as	NULL
those	NULL
described	NULL
in	NULL
this	NULL
report	NULL
suggest	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
SOCS-1	NULL
in	NULL
counterregulating	NULL
STAT	NULL
6	NULL
activity	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
IFNs	NULL
to	NULL
induce	NULL
SOCS-1	NULL
gene	NULL
expression	NULL
provides	NULL
a	NULL
mechanism	NULL
to	NULL
explain	NULL
how	NULL
IFNs	NULL
can	NULL
suppress	NULL
activation	NULL
of	NULL
IL-4-	NULL
and	NULL
IL-13-inducible	NULL
genes	NULL
.	NULL

We	NULL
thank	NULL
Valerie	NULL
Calvert	NULL
for	NULL
preparing	NULL
elutriated	NULL
monocytes	NULL
and	NULL
Dr.	NULL
Douglas	NULL
Hilton	NULL
(	NULL
The	NULL
Walter	NULL
and	NULL
Eliza	NULL
Hall	NULL
Institute	NULL
,	NULL
Parkville	NULL
,	NULL
Australia	NULL
)	NULL
and	NULL
Dr.	NULL
Hiroyuki	NULL
Mano	NULL
(	NULL
Jichi	NULL
Medical	NULL
School	NULL
,	NULL
Tochigi	NULL
,	NULL
Japan	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
SOCS	NULL
cDNAs	NULL
.	NULL

H.L.D	NULL
.	NULL

was	NULL
the	NULL
recipient	NULL
of	NULL
a	NULL
Postgraduate	NULL
Research	NULL
Fellowship	NULL
Award	NULL
from	NULL
the	NULL
Oak	NULL
Ridge	NULL
Institute	NULL
for	NULL
Science	NULL
and	NULL
Education	NULL
through	NULL
an	NULL
interagency	NULL
agreement	NULL
between	NULL
the	NULL
U.S.	NULL
Department	NULL
of	NULL
Energy	NULL
and	NULL
the	NULL
Food	NULL
and	NULL
Drug	NULL
Administration	NULL
.	NULL

1	NULL
.	NULL

-	NULL
Kondo	NULL
,	NULL
M.	NULL
,	NULL
Takeshita	NULL
,	NULL
T.	NULL
,	NULL
Ishii	NULL
,	NULL
N.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Watanabe	NULL
,	NULL
S.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
&	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1874-1877	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

Immunology	NULL
:	NULL
Dickenshects	NULL
et	NULL
al	NULL
.	NULL

Russell	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Harada	NULL
,	NULL
N.	NULL
,	NULL
Nakamura	NULL
,	NULL
Y.	NULL
,	NULL
Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Leland	NULL
,	NULL
P.	NULL
,	NULL
Friedmann	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
Puri	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1880-1883	NULL
.	NULL

Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Miura	NULL
,	NULL
O.	NULL
,	NULL
Lai	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Cwik	NULL
,	NULL
C.	NULL
,	NULL
Liu	NULL
,	NULL
E.	NULL
T.	NULL
&	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
370	NULL
,	NULL
153-157	NULL
.	NULL

Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Tortolani	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
McReynolds	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Kinzer	NULL
,	NULL
C.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

&	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Nail	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
,	NULL
7681-7685	NULL
.	NULL

Chen	NULL
,	NULL
X.	NULL
H.	NULL
,	NULL
Patel	NULL
,	NULL
B.	NULL
K.	NULL
R.	NULL
,	NULL
Wang	NULL
,	NULL
L.-	NULL
M.	NULL
,	NULL
Frankel	NULL
,	NULL
M.	NULL
,	NULL
Ellmore	NULL
,	NULL
N.	NULL
,	NULL
Flavell	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
LaRochelle	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

&	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
6556-6560	NULL
.	NULL

Smerz-Bertling	NULL
,	NULL
C.	NULL
&	NULL
Duschl	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
Chem	NULL
.	NULL

270	NULL
,	NULL
966-970	NULL
.	NULL

Ryan	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
McReynolds	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Keegan	NULL
,	NULL
A.	NULL
,	NULL
Wang	NULL
,	NULL
L.	NULL
,	NULL
Garfein	NULL
,	NULL
E.	NULL
,	NULL
Rothman	NULL
,	NULL
P.	NULL
,	NULL
Nelms	NULL
,	NULL
K.	NULL
&	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
Immunity	NULL
4	NULL
,	NULL
123-132	NULL
.	NULL

Kotanides	NULL
,	NULL
H.	NULL
&	NULL
Reich	NULL
,	NULL
N.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1265-1267	NULL
.	NULL

Hou	NULL
,	NULL
J.	NULL
,	NULL
Schindler	NULL
,	NULL
U.	NULL
,	NULL
Henzel	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Ho	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Brasseur	NULL
,	NULL
M.	NULL
&	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
1701-1706	NULL
.	NULL

Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Shimoda	NULL
,	NULL
K.	NULL
,	NULL
Thierfelder	NULL
,	NULL
W.	NULL
,	NULL
Fischer	NULL
,	NULL
C.	NULL
,	NULL
Kim	NULL
,	NULL
A.	NULL
,	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Cleveland	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Nelms	NULL
,	NULL
K.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
3336-3343	NULL
.	NULL

Vercelli	NULL
,	NULL
D.	NULL
,	NULL
Jabara	NULL
,	NULL
H.	NULL
H.	NULL
,	NULL
Lee	NULL
,	NULL
B.	NULL
W.	NULL
,	NULL
Woodland	NULL
,	NULL
N.	NULL
,	NULL
Geha	NULL
,	NULL
R.	NULL
S.	NULL
&	NULL
Leung	NULL
,	NULL
D.	NULL
Y.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

167	NULL
,	NULL
1406-1416	NULL
.	NULL

McKenzie	NULL
,	NULL
A.	NULL
N.	NULL
J.	NULL
,	NULL
Culpepper	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
de	NULL
Waal	NULL
Malefyt	NULL
,	NULL
R.	NULL
,	NULL
Bricre	NULL
,	NULL
F.	NULL
,	NULL
Punnonen	NULL
,	NULL
J.	NULL
,	NULL
Aversa	NULL
,	NULL
G.	NULL
,	NULL
Sato	NULL
,	NULL
A.	NULL
,	NULL
Dang	NULL
,	NULL
W.	NULL
,	NULL
Cocks	NULL
,	NULL
B.	NULL
G.	NULL
,	NULL
Menon	NULL
,	NULL
S.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
3735-3739	NULL
.	NULL

Conrad	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Kuhn	NULL
,	NULL
H.	NULL
,	NULL
Mulkins	NULL
,	NULL
M.	NULL
,	NULL
Highland	NULL
,	NULL
E.	NULL
&	NULL
Sigal	NULL
,	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
217-221	NULL
.	NULL

Nassar	NULL
,	NULL
G.	NULL
M.	NULL
,	NULL
Morrow	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Roberts	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
II	NULL
,	NULL
Lakkis	NULL
,	NULL
F.	NULL
G.	NULL
&	NULL
Badr	NULL
,	NULL
K.	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
27631-27634	NULL
.	NULL

Fenton	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Buras	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

&	NULL
Donnelly	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

149	NULL
,	NULL
1283-1288	NULL
.	NULL

Vannier	NULL
,	NULL
E.	NULL
,	NULL
Miller	NULL
,	NULL
L.	NULL
C.	NULL
&	NULL
Dinarello	NULL
,	NULL
C.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Nail	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89	NULL
,	NULL
4076-4080	NULL
.	NULL

Muzio	NULL
,	NULL
M.	NULL
,	NULL
Re	NULL
,	NULL
F.	NULL
,	NULL
Sironi	NULL
,	NULL
M.	NULL
,	NULL
Polentarutti	NULL
,	NULL
N.	NULL
,	NULL
Minty	NULL
,	NULL
A.	NULL
,	NULL
Caput	NULL
,	NULL
D.	NULL
,	NULL
Ferrara	NULL
,	NULL
P.	NULL
,	NULL
Mantovani	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Colotta	NULL
,	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
Blood	NULL
83	NULL
,	NULL
1738-1743	NULL
.	NULL

Colotta	NULL
,	NULL
F.	NULL
,	NULL
Re	NULL
,	NULL
F.	NULL
,	NULL
Muzio	NULL
,	NULL
M.	NULL
,	NULL
Bertini	NULL
,	NULL
R.	NULL
,	NULL
Polentarutti	NULL
,	NULL
N.	NULL
,	NULL
Sironi	NULL
,	NULL
M.	NULL
,	NULL
Giri	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Dower	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Sims	NULL
,	NULL
J.	NULL
E.	NULL
&	NULL
Mantovani	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
472-475	NULL
.	NULL

Colotta	NULL
,	NULL
F.	NULL
,	NULL
Re	NULL
,	NULL
F.	NULL
,	NULL
Muzio	NULL
,	NULL
M.	NULL
,	NULL
Polentarutti	NULL
,	NULL
N.	NULL
,	NULL
Minty	NULL
,	NULL
A.	NULL
,	NULL
Caput	NULL
,	NULL
D.	NULL
,	NULL
Ferrara	NULL
,	NULL
P.	NULL
&	NULL
Mantovani	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
12403-12406	NULL
.	NULL

Snapper	NULL
,	NULL
C.	NULL
M.	NULL
&	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
236	NULL
,	NULL
944-947	NULL
.	NULL

Pene	NULL
,	NULL
J.	NULL
,	NULL
Rousset	NULL
,	NULL
F.	NULL
,	NULL
Briere	NULL
,	NULL
F.	NULL
,	NULL
Chretien	NULL
,	NULL
I.	NULL
,	NULL
Bonnefoy	NULL
,	NULL
J.-Y	NULL
.	NULL

,	NULL
Spits	NULL
,	NULL
H.	NULL
,	NULL
Yokota	NULL
,	NULL
T.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
Banchereau	NULL
,	NULL
J.	NULL
,	NULL
ef	NULL
al	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85	NULL
,	NULL
6880-6884	NULL
.	NULL

Thyphronitis	NULL
,	NULL
G.	NULL
,	NULL
Tsokos	NULL
,	NULL
G.	NULL
C.	NULL
,	NULL
June	NULL
,	NULL
C.	NULL
H.	NULL
,	NULL
Levine	NULL
,	NULL
A.	NULL
D.	NULL
&	NULL
Finkelman	NULL
,	NULL
F.	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
5580-5584	NULL
.	NULL

Galizzi	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Cabrillat	NULL
,	NULL
H.	NULL
,	NULL
Rousset	NULL
,	NULL
F.	NULL
,	NULL
Menetrier	NULL
,	NULL
C.	NULL
,	NULL
de	NULL
Vries	NULL
,	NULL
J.	NULL
E.	NULL
&	NULL
Banchereau	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

141	NULL
,	NULL
1982-1988	NULL
.	NULL

Denoroy	NULL
,	NULL
M.	NULL
,	NULL
Yodoi	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Banchereau	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Immunol	NULL
.	NULL

27	NULL
,	NULL
129-134.	NULL
te	NULL
Velde	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Rousset	NULL
,	NULL
F.	NULL
,	NULL
Peronne	NULL
,	NULL
C.	NULL
,	NULL
de	NULL
Vries	NULL
,	NULL
J.	NULL
E.	NULL
&	NULL
Figdor	NULL
,	NULL
C.	NULL
G.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

144	NULL
,	NULL
3052-3059	NULL
.	NULL

Alderson	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Armitage	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Tough	NULL
,	NULL
T.	NULL
W.	NULL
&	NULL
Ziegler	NULL
,	NULL
S.	NULL
F.	NULL
(	NULL
1994	NULL
)	NULL
Cytokine	NULL
6	NULL
,	NULL
407-413	NULL
.	NULL

Sone	NULL
,	NULL
S.	NULL
,	NULL
Orino	NULL
,	NULL
E.	NULL
,	NULL
Mitzuno	NULL
,	NULL
K.	NULL
,	NULL
Yano	NULL
,	NULL
S.	NULL
,	NULL
Nishioka	NULL
,	NULL
Y.	NULL
,	NULL
Haku	NULL
,	NULL
T.	NULL
,	NULL
Nii	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Ogura	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Eur	NULL
.	NULL

Respir	NULL
.	NULL

J	NULL
.	NULL

7	NULL
,	NULL
657-663	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
(	NULL
1999	NULL
)	NULL
-	NULL
10805	NULL
Dickensheets	NULL
,	NULL
H.	NULL
L.	NULL
&	NULL
Donnelly	NULL
,	NULL
R.	NULL
P.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

159	NULL
,	NULL
6226-6233	NULL
.	NULL

Takeda	NULL
,	NULL
K.	NULL
,	NULL
Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Shi	NULL
,	NULL
W.	NULL
,	NULL
Matsumoto	NULL
,	NULL
M.	NULL
,	NULL
Minami	NULL
,	NULL
M.	NULL
,	NULL
Kashiwamura	NULL
,	NULL
S.	NULL
,	NULL
Nakanishi	NULL
,	NULL
K.	NULL
,	NULL
Yoshida	NULL
,	NULL
N.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
&	NULL
Akira	NULL
,	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
380	NULL
,	NULL
627-630	NULL
.	NULL

Shimoda	NULL
,	NULL
K.	NULL
,	NULL
van	NULL
Deursen	NULL
,	NULL
J.	NULL
,	NULL
Sangster	NULL
,	NULL
M.	NULL
Y.	NULL
,	NULL
Sarawar	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Carson	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
Tripp	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Chu	NULL
,	NULL
C.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Nosaka	NULL
,	NULL
T.	NULL
,	NULL
Vignali	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
380	NULL
,	NULL
630-633	NULL
.	NULL

Kaplan	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Schindler	NULL
,	NULL
U.	NULL
,	NULL
Smiley	NULL
,	NULL
S.	NULL
T.	NULL
&	NULL
Grusby	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Immunity	NULL
4	NULL
,	NULL
313-319	NULL
.	NULL

Kohler	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Rieber	NULL
,	NULL
E.	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

23	NULL
,	NULL
3066-3071	NULL
.	NULL

Ohmori	NULL
,	NULL
Y.	NULL
,	NULL
Smith	NULL
,	NULL
M.	NULL
F.	NULL
&	NULL
Hamilton	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

157	NULL
,	NULL
2058-2065	NULL
.	NULL

Kotanides	NULL
,	NULL
H.	NULL
&	NULL
Reich	NULL
,	NULL
N.	NULL
C.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
25555-25561	NULL
.	NULL

Seidel	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Milocco	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Lamb	NULL
,	NULL
P.	NULL
,	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Stein	NULL
,	NULL
R.	NULL
B	NULL
.	NULL

&	NULL
Rosen	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
,	NULL
3041-3045	NULL
.	NULL

Schindler	NULL
,	NULL
U.	NULL
,	NULL
Wu	NULL
,	NULL
P.	NULL
,	NULL
Rothe	NULL
,	NULL
M.	NULL
,	NULL
Brasseur	NULL
,	NULL
M.	NULL
&	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
689-697	NULL
.	NULL

Wahl	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Katona	NULL
,	NULL
I.	NULL
M.	NULL
,	NULL
Wilder	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Winter	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
Haroui	NULL
,	NULL
B.	NULL
,	NULL
Scher	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Wahl	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1984	NULL
)	NULL
Cell	NULL
.	NULL

Immunol	NULL
.	NULL

85	NULL
,	NULL
373-383	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
&	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebovitz	NULL
,	NULL
R.	NULL
M.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

Donnelly	NULL
,	NULL
R.	NULL
P.	NULL
,	NULL
Fenton	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Kaufman	NULL
,	NULL
J.	NULL
D.	NULL
&	NULL
Gerrard	NULL
,	NULL
T.	NULL
L.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

146	NULL
,	NULL
3431-3436	NULL
.	NULL

Starr	NULL
,	NULL
R.	NULL
,	NULL
Willson	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Viney	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Murray	NULL
,	NULL
L.	NULL
J.	NULL
L.	NULL
,	NULL
Rayner	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
Jenkins	NULL
,	NULL
B.	NULL
J.	NULL
,	NULL
Gonda	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Alexander	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Metcalf	NULL
,	NULL
D.	NULL
,	NULL
Nicola	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
387	NULL
,	NULL
917-921	NULL
.	NULL

Feinberg	NULL
,	NULL
A.	NULL
P.	NULL
&	NULL
Vogelstein	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Anal	NULL
.	NULL

Biochem	NULL
.	NULL

132	NULL
,	NULL
6-13	NULL
.	NULL

Ohya	NULL
,	NULL
K.	NULL
,	NULL
Kajigaya	NULL
,	NULL
S.	NULL
,	NULL
Yamashita	NULL
,	NULL
Y.	NULL
,	NULL
Miyazato	NULL
,	NULL
A.	NULL
,	NULL
Hatake	NULL
,	NULL
K.	NULL
,	NULL
Miura	NULL
,	NULL
Y.	NULL
,	NULL
Ikeda	NULL
,	NULL
U.	NULL
,	NULL
Shimada	NULL
,	NULL
K.	NULL
,	NULL
Ozawa	NULL
,	NULL
K.	NULL
&	NULL
Mano	NULL
,	NULL
H.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
27178-27182	NULL
.	NULL

Mikita	NULL
,	NULL
T.	NULL
,	NULL
Campbell	NULL
,	NULL
D.	NULL
,	NULL
Wu	NULL
,	NULL
P.	NULL
,	NULL
Williamson	NULL
,	NULL
K.	NULL
&	NULL
Schindler	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
5811-5820	NULL
.	NULL

Endo	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
Masuhara	NULL
,	NULL
M.	NULL
,	NULL
Yokouchi	NULL
,	NULL
M.	NULL
,	NULL
Suzuki	NULL
,	NULL
R.	NULL
,	NULL
Sakamoto	NULL
,	NULL
H.	NULL
,	NULL
Mitsui	NULL
,	NULL
K.	NULL
,	NULL
Matsumoto	NULL
,	NULL
A.	NULL
,	NULL
Tanimura	NULL
,	NULL
S.	NULL
,	NULL
Ohtsubo	NULL
,	NULL
M.	NULL
,	NULL
Misawa	NULL
,	NULL
H.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
387	NULL
,	NULL
921-924	NULL
.	NULL

Naka	NULL
,	NULL
T.	NULL
,	NULL
Narazaki	NULL
,	NULL
M.	NULL
,	NULL
Hirata	NULL
,	NULL
M.	NULL
,	NULL
Matsumoto	NULL
,	NULL
T.	NULL
,	NULL
Minamoto	NULL
,	NULL
S.	NULL
,	NULL
Aono	NULL
,	NULL
A.	NULL
,	NULL
Nishimoto	NULL
,	NULL
N.	NULL
,	NULL
Kajita	NULL
,	NULL
T.	NULL
,	NULL
Taga	NULL
,	NULL
T.	NULL
,	NULL
Yoshizaki	NULL
,	NULL
K.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
387	NULL
,	NULL
924-929	NULL
.	NULL

Sakamoto	NULL
,	NULL
H.	NULL
,	NULL
Yasukawa	NULL
,	NULL
H.	NULL
,	NULL
Masuhara	NULL
,	NULL
M.	NULL
,	NULL
Tanimura	NULL
,	NULL
S.	NULL
,	NULL
Sasaki	NULL
,	NULL
A.	NULL
,	NULL
Yuge	NULL
,	NULL
K.	NULL
,	NULL
Ohtsubo	NULL
,	NULL
M.	NULL
,	NULL
Ohtsuka	NULL
,	NULL
A.	NULL
,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Ohta	NULL
,	NULL
T.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Blood	NULL
92	NULL
,	NULL
1668-1676	NULL
.	NULL

Wang	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
Zamorano	NULL
,	NULL
J.	NULL
,	NULL
Yoerkie	NULL
,	NULL
J.	NULL
L..	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
&	NULL
Keegan	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
1037-1040	NULL
.	NULL

Losman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Chen	NULL
,	NULL
X.	NULL
P.	NULL
,	NULL
Hilton	NULL
,	NULL
D.	NULL
&	NULL
Rothman	NULL
,	NULL
P.	NULL
(	NULL
1999	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

162	NULL
,	NULL
3770-	NULL
3774	NULL
.	NULL

Gajewski	NULL
,	NULL
T.	NULL
F.	NULL
&	NULL
Fitch	NULL
,	NULL
F.	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
4245-4252	NULL
.	NULL

Venkataraman	NULL
,	NULL
C.	NULL
,	NULL
Leung	NULL
,	NULL
S.	NULL
,	NULL
Salvekar	NULL
,	NULL
A.	NULL
,	NULL
Mano	NULL
,	NULL
H.	NULL
&	NULL
Schindler	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

162	NULL
,	NULL
4053-4061	NULL
.	NULL

Kuperman	NULL
,	NULL
D.	NULL
,	NULL
Schofield	NULL
,	NULL
B.	NULL
,	NULL
Wills-Karp	NULL
,	NULL
M.	NULL
&	NULL
Grusby	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187	NULL
,	NULL
939-948	NULL
.	NULL

Akimoto	NULL
,	NULL
T.	NULL
,	NULL
Numata	NULL
,	NULL
F.	NULL
,	NULL
Tamura	NULL
,	NULL
M.	NULL
,	NULL
Takata	NULL
,	NULL
Y.	NULL
,	NULL
Higashida	NULL
,	NULL
N.	NULL
,	NULL
Takashi	NULL
,	NULL
T.	NULL
,	NULL
Takeda	NULL
,	NULL
K.	NULL
&	NULL
Akira	NULL
,	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

187	NULL
,	NULL
1537-1542	NULL
.	NULL

Naka	NULL
,	NULL
T.	NULL
,	NULL
Matsumoto	NULL
,	NULL
T.	NULL
,	NULL
Narazaki	NULL
,	NULL
M.	NULL
,	NULL
Fujimoto	NULL
,	NULL
M.	NULL
,	NULL
Morita	NULL
,	NULL
Y.	NULL
,	NULL
Ohsawa	NULL
,	NULL
Y.	NULL
,	NULL
Saito	NULL
,	NULL
H.	NULL
,	NULL
Nagasawa	NULL
,	NULL
T.	NULL
,	NULL
Uchiyama	NULL
,	NULL
Y	NULL
.	NULL

&	NULL
Kishimoto	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95	NULL
,	NULL
15577-15582	NULL
.	NULL

